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African mahogany Khaya senegalensis (Desr.) A. Juss (Meliaceae) is a large tree 
growing mainly in the sub-Saharan savannah forests from Senegal to Uganda. This plant 
is one of the most popular medicinal meliaceous plants in traditional African remedies, 
used as a bitter tonic, folk and popular medicine against malaria, fever, mucous diarrhea, 
and venereal diseases as well as an anthelmintic and a taeniacide remedy. Its extracts and 
chemical constituents have been the subject of extensive phytochemical and 
pharmacological investigations since 1960s. Anti-inflammatory, anti-bacterial, 
anthelmintic, and antiplasmodial activities of plant extracts have been reported. 
Limonoids with anti-feeding, feeding deterrent and growth inhibitory properties, anti-
fungal, and anti-sickling activity, as well as dimeric flavonoids with immunostimulating 
activity have been isolated from different parts of this plant. However, none of extracts or 
pure chemicals has been screened for biological activity such as antioxidant activity and 
anti-proliferative capacity against human cancer cell lines. Therefore, the main object of 
this study was to screen bioactive ingredients with anticancer and antioxidant activities 
from the plant through purification, isolation, structural elucidation, and bioassays. 
Eleven natural products were isolated from the methanolic extract of stem bark of 
Khaya senegalensis after extraction and purification, especially through crystallization 
and modern column chromatographic techniques using normal phase and reverse phase 
silica gel columns, Sephadex LH-20, MCI CHP20P, prep-HPLC, etc. Their structures 
were determined to be two ring D-seco limonoids 3α, 7α-dideacetylkhivorin (1) and 1α, 
3α, 7α-trideacetylkhivorin (2), mexicanoloid limonoid khayanone (3), five khayanolide 
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limonoids 1-O-deacetylkhayanolide B (4), khayanolide B (5), khayanolide E (6), 1-O-
deacetylkhayanolide E (7), and novel 6-dehydroxykhayanolide E (8), three lignans (-)-
lyoniresinol (9), (-)-lyoniresin-9-yl-β-D-xylopyranoside (10), and (-)-lyoniresin-4'-yl-β-
D-glucopyranoside (11), respectively, through various spectroscopic methods including 
IR, EI-MS (HREI-MS), LC-ESI-MS (accurate ESI-MS), extensive 1D and 2D NMR (1H , 
13C, DEPT, 1H-1H COSY, HMQC or HSQC, HMBC, NOESY), and X-ray diffraction 
experiments.  
The structures and stereochemistry of 1, 2, 3, 4, 6, and 8 were confirmed through X-
ray crystallography. Based on the X-ray diffraction analyses and NMR data, two reported 
khayanolides 1α-acetoxy-2β,3α,6,8α,14β-pentahydroxy-[4.2.110,30.11,4]-tricyclomeliac-7-
oate 12 and 1α,2β,3α,6,8α,14β-hexahydroxy-[4.2.110,30.11,4]-tricyclomeliac-7-oate 13 are, 
in fact, 1-O-acetylkhayanolide B 4 and khayanolide B 5, respectively, and two reported 
phragmalins methyl 1α-acetoxy-6,8α,14β,30β-tetrahydroxy-3-oxo-[3.3.110,2.11,4]-
tricyclomeliac-7-oate 14 and methyl 1α,6,8α,14β,30β-pentahydroxy-3-oxo-[3.3.110,2.11,4]-
tricyclomeliac-7-oate 15 are, in fact, khayanolide E 6 and 1-O-deacetylkhayanolide E 7, 
respectively. 
In the anti-proliferative bioassay, 1 and 2 showed significant growth inhibitory 
activities against MCF-7, SiHa, and Caco-2 tumor cells with IC50 values in the range of 
35-69 µg/ml, while other compounds did not show anticancer activity even at high 
concentration 200 µg/ml; 9, 10, 11 exhibited strong antioxidant activities comparable to 























































































1  R=Ac  
2  R=H
3
4  R1=Ac   R2=OH R3=H R4=OH 
5  R1=H R2=OH R3=H R4=OH
6  R1=Ac R2=R3=O R4=OH    
7  R1=H   R2=R3=O R4=OH 
8  R1=H   R2=R3=O R4=H
9   R1=H  R2=H  
10 R2=H  R1=xyl 
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CHAPTER 1 INTRODUCTION 
1.1 Botany of Khaya genus 
The Meliaceae, the mahogany family, comprised of 51 genera and approximately 
1400 species, is found primarily in pantropical locations. Many large trees in this family 
are well-known for their high quality timber, especially those in the genera --- Agliaia, 
Aphanamixis, Azadirachta, Carapa, Cedrela, Chukrasis, Dysoxylum, Entandrophragma, 
Guarea, Khaya, Melia, Soymida, Swietenia, and Trichilia (Banerji & Nigam, 1983). The 
most common commercial genus of this family in African is Khaya (African mahogany), 
which is composed of the 5 species: K. anthotheca, K. grandifoliola, K. ivorensis, K. 
nyasica, and K. senegalensis, found all over the world. All the species of the Khaya genus 
are well-known for their high quality hard wood, which is resistant to insect and fungal 
attack (Adesida et al., 1971). In addition, the Khaya genus is closely related to the South 
American genus Swietenia, the original source of mahogany.  
1.2 Botany and distribution of Khaya senegalensis 
The most distinct species, K. senegalensis, is also called “heavy African mahogany” 
because it is darker and heavier than other commercial mahoganies (weight when dried: 
K. anthotheca 540 kg/m3, K. grandifoliola 720 kg/m3, K. ivorensis 530 kg/m3, K. nyasica 
590 kg/m3, and K. senegalensis 800 kg/m3). It is a large evergreen tree, reaching a height 
of approximately 15-24 m and a diameter of approximately 1.0-3.0 m, characterized by a 
dense evergreen crown of dark shining foliage, pinnate leaves, and round capsules. It 
grows primarily in the deciduous savannah forests, especially in the countries of Nigeria, 
Senegal, Sudan, Uganda, and Zaire. Its dark and heavy timber, which is said to provide 
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the best surface-finishing of all the African mahoganies, is a popular timber for lorry 
bodies, construction work, and decking in boats, in addition to its traditional uses for 
furniture (Styles & White, 1991). 
1.3 Medicinal usage of Khaya senegaleneis 
Khaya senegalensis is one of the most popular medicinal meliaceous plants used in 
traditional African remedies. The decoction of its stem bark is commonly used as a bitter 
tonic in folk and popular medicines for malaria, fever, mucous diarrhea, and venereal 
diseases as well as for an anthelmintic and a taeniacide remedy (Iwu, 1993; Olayinka et 
al., 1992). The stem bark extracts and the chemical constituent profile have been the 
subject of extensive phytochemical and pharmacological investigations since the 1960s 
(Adesida et al., 1971; Mulholland et al., 2000; Narender et al., 2007). These plant 
extracts have been reported to exhibit anti-inflammatory effects (Lompo et al., 1998) as 
well as anti-bacterial (Koné et al., 2004), anthelmintic (Ademola et al., 2004), anti-tumor, 
anti-oxidant (Androulakis et al., 2006), and anti-plasmodial activities (El-Tahir et al., 
1998). Two dimeric flavonoids, as well as 2,6-dihydroxy-p-benzoquinone, β-sistosterol, 
and 3-O-glucose-β-sistosterol, catechin, tannins, saponins, polysaccharides, and 
coumarins (Kayser & Abreu, 2001), with immunostimulating activity have been isolated 
from the extracts of its stem bark. Approximately 45 limonoids (Adesida et al., 1971; 
Olmo et al., 1996; Olmo et al., 1997, Govindachari& Kumari 1998; Khalid et al., 1998; 
Govindachari et al., 1999; Mulholland et al., 2000; Abdelgaleil et al., 2003; Tchimene et 
al., 2006) isolated from the different parts (leaf, seed, and stem bark) of this plant 
constitute the bitter principles of the plant extracts. Furthermore, some limonoids 
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exhibited feeding deterrent and growth inhibitory properties (El-Aswad et al., 2003), and 
anti-feeding (Abdelgaleil & Nakatani, 2003), anti-fungal (Govindachari et al., 1998; 
Abdelgaleil et al., 2004), and anti-sickling activities (Fall et al., 1999). 
1.4 Khayanolides from Khaya senegalensis 
The nomenclature limonoid is derived from the compound limonin, one of the 
primary bitter components in citrus fruits. The structural determination of limonin in 
1960 marked the beginning of limonoid (tetranortriterpenoid) chemistry (Arigoni et al., 
1960). These highly oxygenated, modified tetranortriterpenoids are commonly found in 
plants of the families Meliaceae, Rutaceae, Cneoraceae and Simaroubaceae of the order 
Rutals. Approximately 1300 limonoids, exhibiting more than 35 different carbon 
frameworks created through ring fission, re-cyclization, reopening, re-closure, and 
skeletal rearrangements, have been observed over the past five decades, with new 
structural types continuing to appear (Rogers et al., 1998; Tchuendem et al., 1998; Zhang 
et al., 2003; Yuan et al., 2005; Fang et al., 2008). Of these four families, Meliaceae is of 
particular interest because of the abundance and structural diversity of the limonoids 
present in its plant members (Connolly 1983; Taylor, 1984; Champagne et al., 1992; 
Mulholland et al., 2000).  
Specifically, African mahogany Khaya senegalenis (Meliaceae) is a rich source of 
limonoids, exemplifying a wide variety of structural types (Adesida et al., 1971; 
Mulholland et al., 2000; Abdelgaleil et al., 2003). Khayanolide limonoid, first isolated 
from K. senegalensis in 1996, results from a cleavage between C-1, C-2 and a linkage 
between C-1, C-30 of phragmalin (Olmo et al., 1996). Past research has characterized the 
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following 11 khayanolide limonoids in two plants of the Khaya genus: 1-O-
deacetylkhayanolide E from K. grandifoliola (Zhang et al., 2008) and khyanolide A, B, C 
(Abdelgaleil et al., 2001), khayanolide D, E (Nakatani et al., 2002), 1-O-
acetylkhayanolide A (Nakatani et al., 2001), 1-O-acetylkhayanolide B (Abdelgaleil et al., 
2000), 1α-acetoxy-2β,3α,6,8α,14β-pentahydroxy-[4.2.110,30.11,4]-tricyclomeliac-7-oate 
(Olmo et al., 1996), 1α,2β,3α,6,8α,14β-hexahydroxy-[4.2.110,30.11,4]-tricyclomeliac-7-
oate and 1α-acetoxy-3β,6,8α-trihydroxy-2α–methoxy-2β,14β–epoxy-[4.2.110,30.11,4]-
tricyclomeliac-7-oate (Olmo et al., 1997) from K. senegalensis. However, the 
configurations of oxygenated C-6 in these reported khayanolides were not confirmed, 
except for that in khayanolide A, which was determined through X-ray crystallography 
and CD study (Abdelgaleil et al., 2001). 
1.5 Purpose of our study 
Although various pure compounds, including the 45 limonoids, have been identified 
from the plant, none has been screened for antioxidant activity or anti-proliferative 
activity against different human cancer cell lines. A preliminary study (Androulakis et al., 
2006) indicated that the methanolic extract of the stem bark of K. senegalensis exhibited 
antioxidant activities and anti-proliferative, anti-inflammatory and pro-apoptotic effects 
on HT-29, HCT-15, and HCA-7 cells, suggesting that this popular herbal medicine has 
potential as a natural chemopreventive agent for colorectal cancer.  
Based on these results, the report here screened bioactive ingredients in the plant 
guided by anticancer and antioxidant bioassays, investigated the structures of these 
remaining khayanolides fully, and provided solid scientific evidence for the traditional 
5 
medicinal use of the stem bark of Khaya senegalensis. This work was divided into the 
following three stages:  
(1) The extraction, purification and isolation of the stem bark of Khaya senegalensis 
from the Republic of Guinea (West Africa) using a series of modern column 
chromatographic techniques (normal phase and reverse phase C-18 silica gel, Sephadex 
LH-20, MCI gel CHP20P, HPLC-DAD/ELSD, and preparative HPLC-DAD);  
(2) The structural elucidation of the isolates based on spectroscopic methods 
including IR, EI-MS (HREI-MS), LC-ESI-MS (accurate ESI-MS) (positive ion model 
and negative ion model), extensive 1D and 2D NMR (1H, 13C, DEPT, 1H-1H COSY, 
HMQC or HSQC, HMBC, and NOESY), and X-ray diffraction experiments. The 
configuration of oxygenated C-6 in khayanolides was determined through X-ray 
crystallography, the preferred arbiter to confirm the structure and stereochemistry of 
organic compounds. The different C-6 configurations in B,D-seco limonoids found in the 
African mahogany Khaya genus and the original mahogany genus Swietenia were 
analyzed, the results suggesting a significant chemotaxonomy between the two genera. 
(3) Anti-tumor assay against different cell lines (MCF-7, SiHa, and Caco-2 tumor 
cells) and DPPH antioxidant bioassay of the extracts, fractions, and purified single 
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CHAPTER 2 PURIFICATION AND ISOLATION 
2.1 General experimental procedures 
All chemicals used for extraction and separation were analytical grade (Fisher 
Scientific, USA) and were used directly without further purification. The normal phase 
and reverse phase C-18 TLC plates used were purchased from Fisher Scientific. The 
column material reverse phase gel MCI CHP20P (high porous polymer, 37-75 µm) was 
purchased from Mitsubishi Chemical Corporation. The RP C-18 gel (reverse phase C-18, 
40-63 µm) was purchased from Acros Corporation. The Sephadex LH-20 was purchased 
from Amersham Biosciences Corporation. The normal phase silica gel (200-300 mesh) 
was purhcased from Qingdao Haiyang Chemical Corporation. The TLC zones (normal 
phase silica gel and reverse phase C-18) were visualized by exposure to 10% alcohol 
sulfuric acid. Analytical HPLC-PDA (Shimadzu) was used to detect the purity of the 
isolates. 
2.2 Plant material 
The stem bark of Khaya senegalensis was collected from the martime plains near 
Conakry, Republic of Guinea (West Africa), in November 2005 under the supervision of 
Dr. Youssouf Koita, Ministere de Sante Publique, Departement Sante Communautaire, 
Republic of Guinea. A voucher specimen (number 018/INSP/2005) has been deposited at 
the Ministry of Public Health, Republic of Guinea. 
2.3 Extraction and partition 
Air dried stem bark (495 g) of K. senegalensis was grounded using a mechanic 
machine and sieved through a 100 mesh sifter. Then 160 g of the plant powder was 
12 
extracted using 5 L MeOH for 24 h in a Soxhlet extractor, with a total of 3 batches 
needed to process the 495 g of bark. The pooled MeOH extract was filtered through 
cheese cloth, with the clean solution being condensed through a rotary evaporator in 
vacuum to remove the solvents. The 60 g extracts obtained were suspended in 300 ml 
water and then partitioned by 400 ml CHCl3, EtOAC, and n-BuOH three times to achieve 
CHCl3 phase fraction (4.8 g), EtOAC phase fraction (15.2 g), n-BuOH phase fraction 
(20.4 g) and the left H2O phase fraction (6.8 g). All the 4 fractions were bioassayed using 
anti-tumor and antioxidant tests. 
2.4 Purification and isolation 
The concentrated CHCl3 extract was subjected to column chromatography over 
silica gel (particle size 32-63 µM), and the elution was conducted in an increasing 
polarity solvent system using n-hexane, 20% acetone in hexane, 50% acetone in hexane, 
and acetone, respectively. The fractions eluted by 50% acetone in hexane were pooled 
and subjected to column chromatography over reverse phase C18 silica gel (particle size 
40-63 µm) and eluted with H2O: MeOH (1:3). The fractions eluted resulted in compounds 
1 (12 mg), 2 (11 mg) and colorless crystals (35 mg). The X-ray diffraction analysis 
indicated that the crystal was a mixture of two compounds having a ratio 1:1 that were 
difficult to be separated through normal phase column chromatography. As a result, the 
mixture was subjected to semi-preparative-HPLC using a reverse phase C-18 column 
eluted by gradient CH3CN:MeOH:H2O (15:15:70, 18:18:64, 20:20:60, 25:25:50, 
30:30:40 and MeOH). Compound 6 (12 mg) was obtained from the CH3CN:MeOH:H2O 
20:20:60 fractions while 8 (12 mg) was obtained from the MeOH fractions.  
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The concentrated EtOAc fraction (15 g) was separated using a silica gel (32-63 µM) 
column eluted with chloroform/acetone with an increasing gradient of acetone (30:1 to 
pure acetone) to obtain six fractions (F1-F6). The F5 (3.5 g) was further separated into 
five fractions using a silica gel column (CHCl3/MeOH 50:1 to 4:1). Repeated 
chromatography over reverse phase C-18 silica gel (40-63 µm) and Sephadex LH-20 
afforded compound 3 (13 mg) from the sub-fractions 3, 4 (20 mg) from the sub-fraction 4. 
The fraction 4 (3.3 g) was purified using a silica gel column (CHCl3/EtOAc 20:1 to 2:1), 
giving five sub-fractions. Repeated column chromatography afforded compounds 5 (18 
mg) and 7 (7 mg) from the sub-fraction 4.  
The concentrated n-butanol fraction (20.4 g) was subjected to a MCI CHP20P (300 
g, 32-63 µm) column eluted with with an increasing gradient of water/ethanol (water, 5:1, 
3:1 to pure ethanol) to obtain four fractions (F1-F4). The F3 (5 g) was further separated 
into five sub-fractions using a silica gel column with gradient elutes (CHCl3/MeOH/H2O 
20:1:0.1, 10:1:0.1, 4:1:0.1). Repeated chromatography over reverse phase C-18 (40-63 
µm) eluted with MeOH and H2O and Sephadex LH-20 eluted with MeOH afforded 
compounds 9 (33 mg), 10 (29 mg) and 11 (40 mg). 
Suitable block-shaped crystals for further X-ray diffraction of 1, 2, 3 (in CHCl3 and 
MeOH), 4 (in CHCl3), 6 and 8 (in CHCl3 and MeOH) were obtained through 
optimization of the solvent condition for re-crystallization.  
The flow chart of the procedures, beginning with the raw material, the stem bark of 
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Figure 2-1 Flow chart of the purification and isolation 
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CHAPTER 3 STRUCTURAL DETERMINATION OF THE ISOLATES 
3.1 Introduction 
The structures and the stereochemistry of the 11 isolated natural products (1-11) 
(Figure 3-1) were characterized through various spectroscopic methods including IR, MS 
(EI-MS, HREI-MS, LC-ESI-MS, accurate ESI-MS), NMR (1D and 2D NMR 
experiments 1H, 13C, DEPT 90° and 135°, 1H-1H COSY, HMQC or HSQC, HMBC, and 
NOESY), and single crystal X-ray diffraction analyses. Among the isolates, 8 compounds 
(1-8) belong to limonoids (tetranortriterpenoids) and 3 compounds (9-11) are lignans. 
Compound 8 is a novel khayanolides while the findings from the research reported here 
indicates the first isolated compounds, 2, 7, 9, 10, 11, from the title plant. 
The limonoids were elucidated as 3α, 7α-dideacetylkhivorin (1), 1α, 3α, 7α-
trideacetylkhivorin (2), khayanone (3), 1-O-acetylkhayanolide B (4), khayanolide B (5), 
khayanolide E (6), 1-O-deacetylkhayanolide E (7), and 6-dehydroxylkhayanolide E (8). 
These teternortriterpenoids are classified as three different carbon-frame types: (I) 
khivorin limonoids with ring D-seco (1 and 2), (II) mexicanolide limonoid with rings B, 
D-seco and ring B recycles (3), and (III) khayanolide limonoids with a cleavage of C-1, 
C-2 and a link of C-1, C-30 of rearranged phragmalin (4-8).  
The structures and stereochemistry of 1, 2, 3, 4, 6, and 8 were confirmed through X-
ray crystallography. This study is the first report of khayanone 3 as a mexicanolide with a 
6 S configuration as determined through X-ray diffraction analyses. The absolute 
stereochemistry of 1-O-acetylkhayanolide B 4 was determined because of the presence of 
the chlorines of CHCl3 molecules in the crystals.  
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The results obtained here confirmed the structures of khayanolides 4-7 reported in 
2000-2003 by the Nakatani group and have necessitated the structure revision of the four 
limonoids reported in 1996-1997 by the Silvo group, isolated from the same part (stem 
bark) of the same species (K. senegalensis). Two khayanolides 1α-acetoxy-
2β,3α,6,8α,14β-pentahydroxy-[4.2.110,30.11,4]-tricyclomeliac-7-oate 12 and 
1α,2β,3α,6,8α,14β-hexahydroxy-[4.2.110,30.11,4]-tricyclomeliac-7-oate 13 are, in fact, 1-O-
acetylkhayanolide B 4 and khayanolide B 5, respectively, and two phragmalins methyl 
1α-acetoxy-6,8α,14β,30β-tetrahydroxy-3-oxo-[3.3.110,2.11,4]-tricyclomeliac-7-oate 14 and 
methyl 1α,6,8α,14β,30β-pentahydroxy-3-oxo-[3.3.110,2.11,4]-tricyclomeliac-7-oate 15 are, 
in fact, khayanolide E 6 and 1-O-deacetylkhayanolide E 7, respectively (Figure 3-1).  
All the C-6 configurations in khayanolides 4, 5, 6, and 7 were determined to be an S. 
Based on the results from this study and on the biogenetic pathway view, the methyl 6-
hydroxyangolensate in African mahogany K. senegalensis should have a C-6 S 
configuration while methyl 6-hydroxyangolensate in genuine mahogany Swietenia 
species should have a C-6 R configuration. This configuration, different from the 
oxygenated C-6 in B, D-seco limonoids, also suggests a different chemotaxonomy 
between the African mahogany Khaya genus and the genuine mahogany Swietenia genus.  
The three lignans were identified as (-)-lyoniresinol (9), (-) lyoniresin-9-yl-β-D-
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3.2 General instruments and apparatus 
The optical rotation spectrum was obtained using a Perkin-Elmer-341 polarimeter. 
The IR spectrum was recorded using a Nicolet-Magna-750-FTIR spectrometer with KBr 
pellets. The NMR spectra were measured using a Varian Mercury plus 300, a Bruker-
AV-300, a Bruker-DRX-400, or a Bruker-AV-500 instrument with 7-15 mg samples 
dissolved in 0.6 ml CDCl3, CD3OD, or CDCl3+CD3OD solvents with TMS serving as an 
internal reference. The mass spectra were conducted using a Finnigan MAT-95 mass 
spectrometer for EI-MS (HR-EI-MS) and LCQ-Deca or Waters Q-TOF microTM mass 
spectrometer for LC-ESI-MS and accurate ESI-MS. The X-ray diffraction experiments 
were conducted using a Rigaku AFC8S diffractometer with a Mercury CCD detector or a 
Bruker Smart Apex CCD. 
3.3 Structure identification of 3α, 7α-dideacetylkhivorin 1 
Compound 1 is soluble in CHCl3 but not in MeOH. Its molecular formula was 
determined to be C28H38O8 (molecular weight 502) based on accurate ESI-MS (Figure 3-
3) and NMR data (Figures 3-4 to 3-10). As a result, the degree of unsaturation is 10.  
Its 1-D 1H NMR spectrum (Figure 3-4) indicates the presence of 6 singlet methyls 
δ 2.10, 1.23, 1.03, 1.03, 1.01 and 0.90. Twenty-eight carbon signals were observed in the 
13C NMR spectrum (Broad Band Decoupling) (Figure 3-5). The multiplicities of these 
carbons determined through DEPT 135° (Figure 3-6) and DEPT 90° (Figure 3-7) 
resulted in 6 CH3, 4 CH2, 10 CH, and 8 C, including two ester carbonyls (δ 169.6, 168.3), 
a β-substituted furan (δ 142.9, 141.1, 120.8, 110.0), four oxygenated methines (δ 78.6, 
75.9, 74.4, 70.3) and one oxygenated carbon (δ 69.9). Based on the molecular formula 
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and the DEPT spectra, two hydroxyl groups must be present in a molecule of 1. The 
signals of the β-substituted furan ring in the 1H NMR spectrum occurred at δ 7.42 (1H, s, 
H-23), 7.41 (1H, s, H-21), 6.34 (1H, s, H-22) and the corresponding carbon signals at 
142.94 (C-23, d), 141.07 (C-21, d), 109.97 (C-22, d), respectively, in the HMQC 
spectrum (Figure 3-8). The structural fragments of 1 was deduced as they are shown in 
Figure 3-2 from the structures of the furan ring, the singlet of methyl groups, and the 
combination of coupling constants in the 1H NMR spectrum, chemical shift values in the 
1H and 13C NMR spectra, 2-D 1H-1H COSY (Figure 3-9), HMQC and HMBC (Figure 3-
10) spectra. 
Finally, the structure and the relative stereochemistry of 1 were confirmed through 
single crystal X-ray diffraction experiment (Figure 3-11 and Table 3-1). As a result, 
compound 1 was identified to be 3α, 7α-dideacetylkhivorin (Figure 3-1). 
X-ray crystallography confirmed that 1 contains four six-membered rings A—D, 
one three-membered ring E (C14/C15/O5), and one furan ring F linked to atom C17 of 
ring D through a C—C bond in an equatorial position, known as a D-seco type limonoid. 
The ring junctions A/B, B/C and C/D are all trans, while D/E is cis. The six-membered 
rings A—D adopt chair, chair, twist boat and half-chair conformations, while rings E and 
F are fairly planar moieties. The bond lengths and angles are within normal ranges, fairly 
close to their expected values, and the data are comparable with the corresponding values 
in those of a similar D-seco limonoid gedunin (Toscano et al., 1996). The strong classical 
intra-molecular hydrogen bond, O3—H3···O1 and inter-molecular hydrogen-bonding 
interactions O4—H4···O3 connect the molecules to form a network (Table 3-2).  
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Previous results reported that 3α, 7α-dideactylkhivorin 1 was originally isolated 
from the seeds of Khaya nyasica in Tanzania (Adesida et al., 1971) and was also found to 
be present in the fresh seeds of Khaya senegalensis (Govindachari & Kumari, 1998) in 
India and in the stem bark of Khaya ivorensis in the Democratic Republic of Congo 
(Abdelgaleil et al., 2005). Since there is only partial proton data for this compound 
presented in the literature, the 1H and 13C NMR data are unambiguously assigned based 
on 2D NMR experiments as the following: 
3α,7α-dideacetylkhivorin (1): Colorless block-shaped crystals, C28H38O8, 
1H-
NMR (500 M Hz, in CDCl3) δ: 7.42 (1H, s, H-23), 7.41 (1H, s, H-21), 6.34 (1H, s, H-22), 
6.00 (1H, s, H-17), 4.85 (1H, s, H-1), 3.88 (1H, s, H-15), 3.54 (1H, brs, H-7), 3.41 (1H, 
brs, H-3), 2.81 (1H, m, H-9), 2.39 (1H, dd, J =11.0, 7.0 Hz, H-5), 2.29 (1H, m, H-2), 2.10 
(3H, s, OAc), 1.97 (1H, m, H-2), 1.83 (1H, dd, J = 16.0, 11 Hz, H-6), 1.65 (1H, m, H-12), 
1.62 (1H, m, H-11), 1.36 (1H, m, H-6), 1.32 (1H, m, H-11), 1.24 (1H, m, H-12), 1.23 (3H, 
s, H3-18), 1.03 (3H, s, H3-29), 1.03 (3H, s, H3-30), 1.01 (3H, s, H3-19), 0.90 (3H, s, H3-
28); 13C NMR (125 M Hz, in CDCl3 ) δ: 74.42 (C-1), 28.13 (C-2), 75.94 (C-3), 37.39 (C-
4), 34.97 (C-5), 26.58 (C-6), 70.31 (C-7), 43.41 (C-8), 35.20 (C-9), 41.09 (C-10), 14.56 
(C-11), 26.55 (C-12), 38.36 (C-13), 69.91 (C-14), 57.21 (C-15), 168.31 (C-16), 78.61 (C-
17), 17.67 (C-18), 16.60 (C-19), 120.76 (C-20), 141.07 (C-21), 109.97 (C-22), 142.94 (C-
23), 22.12 (C-28), 28.38 (C-29), 18.63 (C-30), 169.59 (OAc), 21.56 (OAc). Accurate 
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The planner structure of 1 was deduced as that on the 
left, after combining the above moieties and checking 
the NMR data including chemical shift values, 
coupling constants in 1-D NMR and the correlations in 
2D NMR COSY and HMBC spectra for confirmation. 
Figure 3-2 The process of planner structure determination of 1 
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Figure 3-3 Accurate ESI-MS spectrum of 1 (3,7-dideacetylkhivorin) 
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Figure 3-4 1H NMR spectrum of 1 (3,7-dideacetylkhivorin) 
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Figure 3-5 13C NMR spectrum of 1 (3,7-dideacetylkhivorin) 
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Figure 3-6 DEPT135° spectrum of 1 (3,7-dideacetylkhivorin) 
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Figure 3-7 DEPT90° spectrum of 1 (3,7-dideacetylkhivorin) 
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Figure 3-8 HMQC spectrum of 1 (3,7-dideacetylkhivorin) 
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Figure 3-9 1H-1H COSY spectrum of 1 (3,7-dideacetylkhivorin) 
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Figure 3-10 HMBC spectrum of 1 (3,7-dideacetylkhivorin) 
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Figure 3-11 Crystal structure of 1 (3, 7-dideacetylkhivorin) 
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Table 3-1 Crystal data and structure refinement of 1 
Crystal description Colorless block  
Empirical formula C28H38O8 
Molecular weight 502.58 
Temperature (K) 298(2) 
Wavelength (Å) 0.71073 
Crystal system, space group Orthorhombic, P212121 
Unit cell dimensions (Å) a = 10.907 (2), b = 14.200 (3), c = 17.391 (4) 
Volume (Å3) 2693.5 (9) 
Number of molecules per unit cell, Z 4 
Calculated density (Mg/m3) 1.239  
Absorption coefficient (µ) (mm-1) 0.09  
Diffraction radiation type  Mo Ka 
F(000) 1080  
Crystal size 0.48 mm × 0.46 mm × 0.29 mm  
θ range for data collection (°) 2.20 < θ < 25.14  
Limiting indices -12 ≤  h ≤ 13, -16 ≤ k ≤ 16, -20 ≤ l ≤ 20  
Reflections collected / unique 23488 / 2485 [Rint = 0.0300]  
Completeness to θ  = 25.14 99.8 %  
Absorption correction REQAB (multi-scan)  
Max. and min. transmission 0.9705 and 0.9355  
Refinement method Full-matrix least-squares on F2  
Data / restraints / parameters 2711 / 0 / 333  
Goodness-of-fit on F2 1.065 
Final R indices [I > 2 σ (I)] R1 = 0.0407, ωR2 = 0.1045 
R indices (all data) R1 = 0.0458, ωR2 = 0.1085 




Table 3-2 hydrogen-bond geometry (Å, °) of compounds 1-3 
 
Compound D-H⋅⋅⋅A D⋅⋅⋅A H⋅⋅⋅A D⋅⋅⋅A D-H⋅⋅⋅A 
O3-H3⋅⋅⋅O1 0.83 2.10 2.810 (2) 143 
O4-H4⋅⋅⋅O3 i 0.83 1.93 2.758 (2) 171 
 
3, 7-dideactyl  
khivorin 1 symmetry code: i x + 0.5, -y + 0.5, -z 
O1-H1A⋅⋅⋅O7 ii 0.83 2.24 3.015 (3) 155 
O4-H4⋅⋅⋅O3 iii 0.83 1.98 2.800 (2) 171 
 
1, 3, 7-trideactyl 
khivorin 2 symmetry code: ii x + 1, y, z; iii x – 0.5, -y + 1.5, -z + 1 
O3-H3⋅⋅⋅O6 iv 0.83 1.877 2.695 168 
O6-H6⋅⋅⋅O10 iv 0.83 1.915 2.740 172.35 
O10-H10B⋅⋅⋅O4 v 0.946 2.002 2.882 53.87 
O10-H10A⋅⋅⋅O11 0.903 2.720 2.902 92.43 
O10-H10B⋅⋅⋅O11 0.946 2.654 2.902 96.50 
O11-H10D⋅⋅⋅O10 0.72 2.351 2.902 157.69 











3.4 Structure identification of 1α, 3α, 7α-trideacetylkhivorin 2 
Compound 2 (Figure 3-1) was soluble in CHCl3 but not in MeOH. Colorless block-
shaped crystals suitable for X-ray diffraction analysis were obtained in both solvents. Its 
structure and relative stereochemistry were determined unambiguously through single 
crystal X-ray diffraction experiments (Figure 3-12 and Table 3-3). As a result, 
compound 2 was identified as 1α, 3α, 7α-trideacetylkhivorin. The compound was 
reported as a synthetic derivative through basic hydrolysis of khivorin (Bevan et al., 1963) 
and recently isolated as a natural product from Khaya ivorensis (Abdelgaleil et al., 2005). 
Similar to compound 1, 2 contains four six-membered rings A–D, one three-
membered ring E, and one furan ring F linked to ring D through a C—C bond in an 
equatorial position. The ring junctions A/B, B/C and C/D are all trans, while D/E is cis. 
The six-membered rings A–D adopt chair, chair, twist boat and half-chair conformations, 
while rings E and F are essentially planar. The five-membered furan ring is disordered by 
a 180° rotation between the C17—C20 bond. All the bond lengths and angles are close to 
their expected values, and the data are comparable with the corresponding values of 
gedunin (Toscano et al., 1996) (Figure 3-13) and of 1,3-dideacetylkhivorin 1. Compound 
2 exhibits strong classical intermolecular O1—H1A···O7, O4—H4···O3 hydrogen bond 
interactions linking the molecules to a stabilized network (Table 3-2). Compounds 1 and 
2 are typical D-seco khivorin limonoids (Figure 3-13), which can be further transformed 
to B,D-seco limonoids, such as methyl angosenlate, commonly regarded as a precursor 
for mexicanolide limonoid (Mulholland et al., 2000). 
34 
 
Figure 3-12 Crystal structure of 2 (1, 3, 7-trideacetylkhivorin) 
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Table 3-3 Crystal data and structure refinement of 2 
Crystal description Colorless block  
Empirical formula C26H36 O7 
Molecular weight 460.55  
Temperature (K) 153 (2) 
Wavelength (Å) 0.71073 
Crystal system, space group Orthorhombic, P212121 
Unit cell dimensions (Å) a = 9.856 (2), b = 14.492 (3), c = 15.714 (3) 
Volume (Å3) 2244.5 (8) 
Number of molecules per unit cell, Z 4 
Calculated density (Mg/m3) 1.363  
Absorption coefficient (µ) (mm-1) 0.10  
Diffraction radiation type  Mo Ka 
F(000) 992  
Crystal size 0.41 mm × 0.41 mm × 0.31 mm  
θ range for data collection (°) 3.30 < θ < 25.10  
Limiting indices -8 ≤  h ≤ 11, -17 ≤ k ≤ 17, -18 ≤ l ≤ 18  
Reflections collected / unique 16840 / 2485 [Rint = 0.037]  
Completeness to θ  = 25.14 99.8 %  
Absorption correction REQAB (multi-scan)  
Max. and min. transmission 0.961 and 0.970 
Refinement method Full-matrix least-squares on F2  
Data / restraints / parameters 2485 / 0 / 306  
Goodness-of-fit on F2 1.071 
Final R indices [I > 2 σ (I)] R1 = 0.0366, ωR2 = 0.0912 
R indices (all data) R1 = 0.0387, ωR2 = 0.0944  



















































































































































Figure 3-13 Chemical structures of 1-3 and related compounds in literature 
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3.5 Structure identification of khayanone 3  
Compound 3 (Figure 3-1) was obtained as colorless block-shaped crystals in CHCl3 
and CH3OH solvents. Its molecular formula was determined to be C27H35O9 (molecular 
weight 502) based on accurate ESI-MS (Figure 3-14) and NMR data (Figures 3-15 and 
3-16). Its NMR data are in good agreement with those reported for khayanone (Nakatani 
et al., 2001), isolated from the stem bark of the same plant species, K. senegalensis, and 
elucidated through NMR and CD spectral analyses. 
Single crystal X-ray diffraction experiments were conducted to determine the 
structure and the stereochemistry (Figure 3-17), specifically the configuration of 
oxygenated C-6. X-ray crystallography confirmed the structure of khayanone reported by 
the Nakatani group. This structure (Figure 3-1) is similar to that of mexicanolide with the 
absolute configurations of C-13 R and C-17 R (Sanni et al., 1987). Refinement of the 
Flack parameter failed to determine the absolute configuration of 3 because of the 
absence of heavy atoms. On the basis of the similarity to the biogenetic pathway of 
mexicanolide limonoids in nature, compound 3 has been assigned the name of 6S, 8α-
dihydroxy-14,15-dihydrocarapin. The S configuration of C6 is different from those from 
X-ray diffraction analysis of swietenine (C-6 R) originally isolated from southern 
American mahogany Swietenia macrophylla (Solomon et al., 2003) or 6R, 8α-
dihydroxycarapin isolated from African mahogany Khaya anthotheca (Tchimene et al., 
2005) (Figure 3-13). This finding appears to be the first report of a 6S configuration of 
mexicanolide limonoid revealed through X-ray diffraction analyses. 
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The six-membered rings A and B exist in boat conformations, the rings C and D in 
chair conformations, and the furan ring is planar. The crystal structure is stabilized by 
classic intermolecular hydrogen bonds (O3-H3⋅⋅⋅O6 and O6-H6⋅⋅⋅O10) and C-H⋅⋅⋅O 
interactions (Table 3-2). In addition, It should be pointed out that there are two 
independent water molecules of crystallization, one (O10) is 100% occupied and the 
second (O11) is 12.5% occupied. In total, 9 water molecules are present in one crystal 
unit cell. 
Khayanone 3 (6S, 8α-dihydroxy-14,15-dihydrocarapin): 1H NMR (in CDCl3 and 
trace amount of CD3OD, 300 MHz, ppm) δ 7.37 (1H, s, H-21), 7.36 (1H, s, H-23), 6.29 
(1H, brs, H-22), 5.52 (1H, s, H-17), 4.34 (1H, s, H-6), 3.75 (3H, s, OMe), 3.03 (1H, d, J = 
9.6 Hz, H-2), 2.81 (1H, d, J = 15 Hz, H-30β), 2.70 (1H, d, J =19.2 Hz, H-15α), 2.67 (1H, 
brs, H-5), 2.61 (1H, dd, J = 19.2, 7.8 Hz, H-15β), 2.29 (1H, dd, J = 15, 9.6 Hz, H-30α), 
1.80 (1H, dd, J = 13.5, 5.0 Hz, H-9), 1.75 (1H, m, H-11β), 1.66 (1H, m, H-12 α), 1.60 
(1H, m, H-14), 1.29 (3H, s, H3-19), 1.20 (3H, s, H3-29), 1.15 (3H, s, H3-28), 1.08 (1H, 
brdt, J = 12.5, 2.4, H-11α), 1.06 (1H, m, H-12), 0.90 (3H, s, H3-18); 
13C NMR (in CDCl3 
and trace amount of CD3OD, 75 MHz, ppm) δ 213.33 (C-1), 54.43 (C-2), 214.61 (C-3), 
50.31 (C-4), 46.04 (C-5), 70.64 (C-6), 175.81 (C-7), 72.81 (C-8), 61.32 (C-9), 50.32 (C-
10), 22.71 (C-11), 35.04 (C-12), 35.39 (C-13), 51.04 (C-14), 26.73 (C-15), 171.68 (C-16), 
77.29 (C-17), 23.71 (C-18), 23.82 (C-19), 120.97 (C-20), 141.13 (C-21), 109.91 (C-22), 
143.22 (C-23), 23.95 (C-28), 23.81 (C-29), 38.90 (C-30), 63.07 (OMe). Accurate ESI-MS 







Figure 3-14 Accurate ESI-MS spectrum of 3 (khayanone)  
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Figure 3-15 1H NMR spectrum of 3 (khayanone) 
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Figure 3-16 13C NMR spectrum of 3 (khayanone) 
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Figure 3-17 Crystal structure of 3 (khayanone) 
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Table 3-4 Crystal data and structure refinement of 3 
Crystal description Colorless plate 
Empirical formula C27H34 O9·1.125 H2O 
Molecular weight 522.81 
Temperature (K) 163(2) 
Wavelength (Å) 0.71073 
Crystal system, space group Tetragonal, P41212 
Unit cell dimensions (Å) a = 13.2315(19), c = 29.118(6) 
Volume (Å3) 5097.8 (15) 
Number of molecules per unit cell, Z 8 
Calculated density (Mg/m3) 1.362 
Absorption coefficient (µ) (mm-1) 0.104 
Diffraction radiation type  Mo Ka 
F(000) 2234  
Crystal size 0.65 mm × 0.38 mm × 0.29 mm  
θ range for data collection (°) 2.08 < θ < 25.14  
Limiting indices -15 ≤  h ≤ 15, -15 ≤ k ≤ 12, -34 ≤ l ≤ 30  
Reflections collected / unique 30465 / 4552 [Rint = 0.0300]  
Completeness to θ  = 25.14 99.8 %  
Absorption correction REQAB (multi-scan)  
Max. and min. transmission 0.9705 and 0.9355  
Refinement method Full-matrix least-squares on F2  
Data / restraints / parameters 4552 / 0 / 350  
Goodness-of-fit on F2 1.138  
Final R indices [I > 2 σ (I)] R1 = 0.0375, ωR2 = 0.0906  
R indices (all data) R1 = 0.0409, ωR2 = 0.0921  
Largest diff. peak and hole (e Å-3) 0.221 and -0.201  
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3.6 Structure identification of 1-O-acetylkhayanolide B 4 
Compound 4 (Figure 3-1) is not soluble either in CHCl3 or in CH3OH, but is 
soluble in a mixture of CHCl3 and MeOH solvents. Its molecular formula was determined 
to be C29H36O11 (molecular weight 560) based on accurate ESI-MS (m/z 561.2185 
[M+H]+, 1121.4210 [2M+H]+) (Figure 3-18) and NMR data.  
Its 1D (Figures 3-19 to 3-22) and 2D NMR data (Figures 3-23 to 3-25) measured in 
CDCl3 and trace CD3OD are in good agreement with those of 1-O-acetylkhayanolide B 
obtained in CDCl3 and trace CD3OD (Abdelgaleil et al., 2000) and 1α-acetoxy-
2β,3α,6,8α,14β-pentahydroxy-[4.2.110,30.11,4]-tricyclomeliac-7-oate 12 (Figure 3-1) tested 
in CDCl3 and trace DMSO-D6 (Olmo et al., 1996), both isolated from the stem bark of 
the same species, K. senegalensis. All (Tables 3-5) indicated similar chemical shift 
values, coupling constants, H-C long-range correlations and coupling patterns. However, 
the structures of 1-O-acetylkhayanolide B and 12 described in literature were found to 
differ in planar structures (i.e., an ether linkage between C-2 and C-14 in 1-O-
acetylkhayanolide B vs. two independent hydroxyl groups at C-2 and C-14 in 12) and in 
stereochemistry (i.e., a β orientation of C-3 hydroxyl group and an assumed S 
configuration of C-6 in 1-O-acetylkhayanolide B vs. an α orientation of C-3 hydroxyl and 
an unresolved configuration of C-6 in 12). This discrepancy and the unconfirmed 
configuration of C-6 prompted the use of CHCl3 solvent to obtain colorless block-shaped 
crystals suitable for X-ray diffraction. As a result, this research conducted an in-depth 3D 
structure study of 4 using single crystal X-ray diffraction analysis to determine its 
structure and stereochemistry. 
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The crystal structure of 4 with its atomic labeling shown in Figure 3-27 confirms the 
structure of 1-O-acetylkhayanolide B reported by the Nakatani group (Abdelgaleil et al., 
2000). The crystal data are listed in Table 3-6. The X-ray crystallography, however, did 
not support 2,14-dihydroxyl groups in 12 as described by the Silva group, as perhaps they 
did not conduct a mass spectroscopy (Olmo et al., 1996). In addition, stereochemistry 
analysis obtained through the X-ray crystallography revealed that the five-membered-
rings A1 (C-1, 29, 4, 5, and 10), B1 (C-1, 30, 8, 9, and 10) and B2 (C-2, 30, 8, 14 and O) 
have half-chair conformations and the furan ring E is planar while the six-membered ring 
A2 (C-1, 30, 2, 3, 4 and 29) has a distorted chair conformation and rings C (C-8, 9, 10, 11, 
12, 13, and 14) and D (C-17, 13, 14, 15, 16, and O) exhibit a chair conformation. The 
spatial proximity of 3.37 Å. between H-3 (α orientation) and H-5 (β orientation) results in 
the correlation observed between H-3 and H-5 in NOESY although they are on different 
sides of the plane. The 33.2º dihedral angle of H (2)-C (2)-C (3)-H (3) accounts for the 
coupling constant value JH-2,H-3  = 6.5 Hz. Although the JH-2,H-3 value and NOE correlation 
between H-3 and H-5 are the same, the conclusions from these results reported here differ 
from those of the Silva group (Olmo et al., 1996) concerning a boat conformation of the 
six-membered ring A2 (C-1, 2, 3, 4, 29, 30) and an H-3 β orientation in 12. 
Furthermore, the absolute configuration of C-6 in 4 was confirmed as an S on the 
basis of the anomalous scattering of the chlorines of the CHCl3 molecules in the crystal. 
The Flack parameter (Flack, 1983) was used to confirm that the correct absolute 
configuration is the one presented in Figure 3-1. Based on these results, it was concluded 
that khayanolide 12 is, in fact, 1-O-acetylkhayanolide B 4 (Figure 3-26). 
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Table 3-5 NMR data of 4 and those reported in the literature 
Num.  4a 4a, # 12b 
 H C H C H C 
1  91.2  91.4  91.1 
2 4.43 (dd, 6.5, 9.5) 72.1 4.52 (dd, 6.7, 9.7) 72.0 4.45 (dd, 6.7, 9.5) 72.0 
3 3.39 (d, 6.5) 78.2 3.48 (d, 6.7) 78.1 3.39 (brd, 6.7) 78.1 
4  43.7  44.1  44.1 
5 2.99 (d, 8.0) 39.1 3.02 (d, 7.4) 39.4 2.93 (d, 7.0) 39.1 
6 4.10 (d, 8.0) 71.1 4.22 (d, 7.4) 71.6 4.15 (d, 7.0) 71.5 
7  175.3  175.2  175.1 
8  86.6  86.3  86.8 
9 2.17 (d, 7.0) 55.2 2.22 (d, 7.6) 55.8 2.16 (brd, 7.0) 55.9 
10  61.0  61.2  60.9 
11 α 1.78 (m) 16.3 1.85 (m) 16.4 ------ 16.4 
    β 1.56 (m)  1.77 (m)  ------  
12 α 0.90 (m) 26.1 0.99 (m) 26.1 0.81 (m) 26.0 
     β 1.78 (m)  1.84 (m)  ------  
13  37.6  37.7  37.5 
14  81.5  81.6  81.5 
15 α 2.97 (d, 17.5) 31.9 3.05 (d, 18.8) 31.9 3.04 (d, 18.7) 32. 0 
    β 2.68 (d, 17.5)  2.75 (d, 18.8)  2.69 (d, 18.7)  
16  171.6  170.9  170.3 
17 5.58 (s) 81.1 5.60 (s) 80.9 5.50 (s) 80.5 
18 1.02 (s) 14.4 1.10 (s) 14.4 1.05 (s) 14.4 
19 1.20 (s) 18.0 1.29 (s) 18.0 1.21 (s) 18.1 
20  120.5  120.6  120.6 
21 7.39 (s) 141.0 7.45 (brd, 1.7) 141.0 7.33 (m) 140.9 
22 6.34 (s) 110.0 6.40 (brd, 1.7) 110.0 6.33 (m) 110.1 
23 7.33 (s) 142.7 7.40 (t, 1.7) 142.7 7.37 (m) 142.6 
28 0.99 (s) 19.0 1.11 (s) 19.2 1.03 (s) 19.3 
29 1.75 (d, 12.0) 41.3 1.83 (d, 12.2) 41.2 2.23 (d, 12.2) 41.1 
 2.21 (d, 12.0)  2.30 (d, 12.2)  1.74 (d, 12.2)  
30 3.10 (d, 9.5) 58.5 3.18 (d, 9.7) 58.8 3.15 (d, 9.5) 58.7 
OMe 3.70 (s) 52.2  52.5 3.69 (s) 52.2 
OCOMe 1.97 (s) 171.0 3.77 (s) 170.7 1.97 (s) 170.4 
  21.7 2.03 (s) 21.7  22.0 
Note: δ in ppm relative to the internal TMS, multiplicities (s, single; d, double; t, triplet; m, multiplet; br, 
broad; and coupling constants (J inHz) are given in brackets. Assignments are based on extensive 2D NMR 
data including COSY, HMQC and HMBC. # data are from previous literature. “------” data are absent. The 
assignments of H-2, 30 of 12 from references were exchanged for comparison with a underline marker. a in 
CDCl3 and trace CD3OD; 
b in CDCl3 and trace DMSO-D6.  
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Figure 3-18 Accurate ESI-MS spectrum of 4 (1-O-acetylkhayanolide B) 
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Figure 3-19 1H NMR spectrum of 4 (1-O-acetylkhayanolide B) 
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Figure 3-20 13C NMR spectrum of 4 (1-O-acetylkhayanolide B) 
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Figure 3-21 DEPT135° spectrum of 4 (1-O-acetylkhayanolide B) 
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Figure 3-22 DEPT90° spectrum of 4 (1-O-acetylkhayanolide B) 
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Figure 3-23 HMQC spectrum of 4 (1-O-acetylkhayanolide B) 
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Figure 3-24 1H-1H COSY spectrum of 4 (1-O-acetylkhayanolide B)  
54 
 





















































































































































































Figure 3-27 Crystal structure of 4 (1-O-acetylkhayanolide B) 
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Table 3-6 Crystal data and structure refinement of 4 
Crystal description Colorless block  
Empirical formula C29H36 O11·0.79CHCl3 
Molecular weight 654.70 
Temperature (K) 298 (2) 
Wavelength (Å) 0.71073 
Crystal system, space group Monoclinic, P21 
Unit cell dimensions (Å) a = 8.2283 (16), b = 11.057(2) 
c = 17.704(4), β = 99.68(3)º 
Volume (Å3) 1587.8(5) 
Number of molecules per unit cell, Z 2 
Calculated density (Mg/m3) 1.369  
Absorption coefficient (µ) (mm-1) 0.293 
Diffraction radiation type  Mo Ka 
F(000) 687  
Crystal size 0.50 mm × 0.24 mm × 0.12 mm  
θ range for data collection (°) 2.94 < θ < 25.05 
Limiting indices -9 ≤  h ≤ 9, -12 ≤ k ≤ 13, -21 ≤ l ≤ 21 
Reflections collected / unique 16840 / 2485 [Rint = 0.037]  
Completeness to θ  = 25.05 99.3 %  
Absorption correction REQAB (multi-scan)  
Max. and min. transmission 0.9657 and 0.8673 
Data / restraints / parameters 5305 / 1 / 406 
Goodness-of-fit on F2 1.096 
Final R indices [I > 2 σ (I)] R1 = 0.0513, ωR2 = 0.1430 
R indices (all data) R1 = 0.0539, ωR2 = 0.1447 
Absolute structure parameter 0.04 (12) 




3.7 Structure identification of khayanolide B 5 
Compound 5 (Figure 3-1) was found to have the molecular formula of C27H34O10 
(molecular weight 518) as determined through ESI-MS (m/z 519.2224 [M+H]+, 541.2013 
[M+Na]+) (Figure 3-28) and NMR experiments. Its NMR data (Tables 3-7) are similar to 
those of 1-O-khayanolide B 4 except for the absence of the acetyl group at C-1. The low-
frequency shift of δ 84.0 (C-1) in 5 and δ 91.2 (C-1) in 4 suggests 5 is khayanolide B, a 
conclusion supported by the 2D NMR experiments. In fact, the NMR data of 5 are in 
good agreement with those reported for khayanolide B (Abdelgaleil et al., 2001) and 
khayanolide 1α,2β,3α,6,8α,14β-hexahydroxy-[4.2.110,30.11,4]-tricyclomeliac-7-oate 13 
(Olmo et al., 1996) (Figure 3-1), both isolated from the stem bark of the same species, K. 
senegalensis. Since the only difference between 13 and 12 is a substitute group change at 
C-1 and khayanolide 12 was found to be the same as 4 through X-ray crystallography 
analysis, it was concluded based on spectral correlation that khayanolide 13 is, in fact, 
khayanolide B 5. In addition, the biogenetic pathway indicates the configuration of 
oxygenated C-6 of 2 is an S, the same as that in 4. {Note: (1) The Nakatani group 
(Abdelgaleil et al., 2001) reported the MS data of khayanolide as HRFABMS m/z 
519.2079 [M+H]+, calcd for C27H35O10 519.2231. The Silvo group reported (Olmo et al., 
1996) the following EI-MS m/z (rel. int.) data: 518 [M-H2O]
+ (73), 380 (100), 95 (80). 
Based on these data, it is concluded that peak 518 is the molecular ion peak. (2) 1-O-
acetyllkhayanolide and corresponding 1-O-deacetyl khayanolide co-occurred as a pair 
frequently in Khaya senegalensis, for example as khayanolide A, 1-O-khayanolide A, 1-
O-acetylkhayanolide B, khayanolide B (Abdelgaleil et al., 2003).} 
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Figure 3-28 Accurate ESI-MS spectrum of 5 (khayanolide B) 
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Table 3-7 NMR data of 5 and those reported in literatures 
Num.  5 a 5a, # 13b 
 H C H C H C 
1  84.0  84.3  83.5 
2 4.26 (dd, 6.5,9.5) 72.3 4.50 (dd ,9.5, 8.6) 72.2 4.45 (dd, 9.5, 6.7) 72.3 
3 3.20 (d, 6.5) 78.6 3.41 (d, 6.8) 78.5 3.42 (brd, 6.7) 78.2 
4  42.7  42.7  42.7 
5 3.00 (d, 7.8) 40.9 3.05 (d, 7.3) 40.9 2.88 (d, 6.8) 40.8 
6 4.12 (d, 7.8) 71.3 4.21 (d, 7.3) 71.6 4.03 (dd, 6.8, 3.6) 71.4 
7  175.3  175.4  175.1 
8  86.9  87.0  86.6 
9 2.20 (d, 7.6) 55.5 2.09 (d, 8.1) 56.1 2.03 (brd, 9.0) 55.3 
10  59.3  59.4  59.2 
11 α 1.85 (m) 16.3 1.86 m 16.5 1.60 m 16.4 
    β 1.75 (m)  1.74 m  1.74 m  
12 α 0.91 (m) 26.1 0.97 m 26.0 0.62 (brd, 12.0) 25.9 
     β 1.81 (m)  1.85 m  1.78 m  
13  37.6  37.7  37.1 
14  81.5  81.5  80.7 
15 α 3.04 (d, 17.5) 32.0 3.14 (d, 18.8) 32.0 2.86 (d, 12.0) 32.3 
    β 2.67 (d, 17.5)  2.78 (d, 18.8)  2.63 (d, 12.0)  
16  171.5  171.4  170.5 
17 5.55 (s) 81.1 5.61 (s) 81.0 5.61 (s) 81.0 
18 1.02 (s) 14.4 1.10 (s) 14.4 0.96 (s) 14.5 
19 1.24 (s) 17.8 1.21 (s) 17.7 1.07 (s) 18.6 
20  120.5  120.7  121.3 
21 7.41 (s) 141.0 7.45 (brs, 0.7) 140.9 7.58 (m) 141.2 
22 6.34 (s) 110.0 6.41 (dd, 1.7, 0.7) 110.0 6.45 (m) 110.5 
23 7.35 (s) 142.7 7.40 (t, 1.7) 142.6 7.62 (m) 143.2 
28 0.95 (s) 19.1 1.09 (s) 19.2 0.95 (s) 19.7 
29pro-R 1.70 (d, 12.0) 44.5 1.88 (d, 12.2) 44.6 1.68 (d, 12.0) 45.3 
    Pro-S 2.13 (d, 12.0)  1.37 (d, 12.2)  1.16 (d, 12.0)  
30 2.88 (d, 9.5) 63.2 2.60 (d, 9.5) 63.3 2.48 (d, 9.2) 63.1 
OMe 3.62 (s) 52.2 3.77 52.1 3.57 (s) 51.4 
Note: # data reported in the literature. δ in ppm relative to the internal TMS, multiplicities (s, single; d, 
double; t, triplet; m, multiplet; br, broad; and coupling constants (J inHz) are given in brackets. 
Assignments are based on extensive 2D NMR data including COSY, HMQC and HMBC. a in CDCl3 and 
trace CD3OD; 
b in CDCl3 and trace DMSO-D6. The proton signals of hydroxyls in 13 were also observed as 
δ 5.41 (d, 3.6 C-6, OH), 4.95 (brs), 4.50 (brs), 3.70 (d, 9.0, C-3 OH) reported in the literature. 
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3.8 Structure identification of khayanolide E 6 
Compound 6 (Figure 3-1) is not soluble in MeOH but is soluble in the mixed 
solvents of CHCl3 and MeOH. Its molecular formula was determined to be C29H34O11 
(molecular weight 558) based on LC-ESI-MS (negative ion mode m/z 603.7 
[M+HCOOH-H]+, 1115.6 [2M-H]+ and positive ion mode m/z 559.3 [M+H]+, 581.3 
[M+Na]+, 1117.5 [2M+H]+, 1139.4 [2M+Na]+) (Figures 3-29 and 3-30) and NMR data 
(Figures 3-31 to 3-33).  
Its NMR data (Table 3-8) are in good agreement with those of khayanolide E 
(Nakatani et al., 2002) and phragmalin derivative methyl 1α-acetoxy-6,8α,14β,30β-
tetrahydroxy-3-oxo-[3.3.110,2.11,4]-tricyclomeliac-7-oate 14 (Figure 3-1) (Olmo et al., 
1997), both isolated from the stem bark of the same plant species, K. senegalensis. 
However, the following differences between khayanolide E and 14 have been reported in 
past research: Khayanolide E exhibits an ether linkage between C-2 and C-14 and a 
proposed 6 S configuration while 14 exhibits two independent hydroxyl groups at C-14 
and C-30 and an unresolved C-6 configuration; furthermore, khayanolide E is a 
khayanolide limonoid while 14 is a phragmalin limonoid because of the locations of C-2 
and C-30. In addition, khayanolide E and 14 have essentially identical spectroscopic 
properties. These structural differences resulted in an in-depth 3D structure study of 6 
using single crystal X-ray diffraction analysis. The block-shaped crystals suitable for X-
ray diffraction experiments were obtained from the mixture solvents of CHCl3 and 
MeOH with slow solvent evaporation at room temperature. The crystal data of 6 are listed 
in Table 3-9. 
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The crystal structure of 6 with its atomic labeling shown in Figure 3-34 confirmed 
the structure of khayanolide E reported by the Nakatani group (Nakatani et al., 2002), 
indicating that khyanolide 14 is the same as khayanolide E 6.  
The reasons that the Silvo group (Olmo et al., 1997) concluded phragmalin 14, not 
khayanolide 6, were perhaps based on the following three factors: (1) they did not 
observe the molecular ion peak in the EI-MS spectrum report as EI-MS m/z (rel. int.): 446 
[M-(CH2=CO+HCOCOOMe)]
+, (100), 168 (15) (Olmo et al., 1997). (2) they did not 
consider other possibilities besides phragmalin as being compatible with the 2D NMR 
data. It was taken for granted at that paper phragmalin limonoid was an intermediate from 
mexicanolide to khayanolide based on the view of biogenetic pathway (Olmo et al., 1996; 
Olmo et al., 1997), leading to the proposed structure of phragmalin; (3) they did not take 
into account the important HMBC correlations between H-30 (1H, δ 3.28, d, J = 10.5) 
and C-9 (δ 55.1, CH), and between H-2 (1H, δ 4.34, d, J = 10.5) and C-4 (δ 51.4, C), 
observed in both the experiments reported here and those of the Nakatani group. These 
three factors proved critical in determining the structural similarities and differences 
between khayanolides and phragmalins. 
Although phragmalin may be an intermediate in the transformation from 
mexicanolide to khayanolide (Figure 3-35) in nature on the basis of the biogenetic 
pathway, until recently, no other phragmalins have been isolated and reported from the 
Khaya genus except the incorrect 14 and the following 15. Perhaps the concentration of 
phragmalin in the plants is too low or it is easily transformed to khayanolide with specific 
enzymes. 
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Table 3-8 NMR data of 6 and those reported in literatures 
Num.  6a 6# a 14c 
 H C H C H C 
1  90.8  91.4  90.1 
2 4.34 (d, 10.5) 74.3 4.38 (d, 10.5) 74.0 4.40 (d, 10.4) 74.1 
3  205.8  204.8  205.4 
4  51.4  52.3  50.5 
5 2.87 (brd,4.8) 40.9 3.02 (d, 4.9) 42.1 3.07 (d, 8.4) 40.0 
6 4.32 (d, 4.8) 70.7 4.34 (d, 4.9) 71.7 4.13 (8.4,5.0) 69.6 
7  174.4  174.9  173.4 
8  86.8  87.7  86.6 
9 2.20 (d, 9.3) 55.1 2.36 (brd,9.5) 57.6 2.30 (brd 8.4) 54.5 
10  61.6  62.1  60.9 
11 α 1.86 (m) 16.4 1.92 (m) 16.7 1.64-1.72 (m) 16.4 
    β 1.53 (m)  1.54 (m)  1.90 (m)  
12 α 0.83 (m) 26.0 0.94 (m) 26.9 0.74 (brd,10.8) 26.4 
     β 1.63 (m)  1.71 (m)  1.64-1.72 (m)  
13  37.5  37.5  37.0 
14  83.5  83.3  83.4 
15 α 3.06 (d, 18.6) 32.7 3.08 (d, 18.8) 32.5 2.96 (d, 18.8) 33.0 
    β 2.58 (d, 18.6)  2.64 (d, 18.8)  2.72 (d, 18.8)  
16  171.6  170.0  169.7 
17 5.44 (s) 80.9 5.52 (s) 79.9 5.26 (s) 80.0 
18 1.03 (s) 14.2 1.10 (s) 14.2 1.03 (s) 14.7 
19 1.34 (s) 18.6 1.41 (s) 20.1 1.33 (s) 18.0 
20  120.4  120.6  120.7 
21 7.34 (s) 141.1 7.40 (brs) 141.1 7.68 (s) 141.7 
22 6.30 (s) 110.0 6.36 (d, 1.5) 110.1 6.47 (s) 110.5 
23 7.33 (s) 142.9 7.39 (t, 1.7) 142.9 7.67 (s) 143.5 
28 1.27 (s) 15.3 1.26 (s) 15.9 0.92 (s) 15.1 
29 2.08 (d, 12.6) 40.8 2.12 (d, 12.7) 40.7 2.04 (d, 10.0) 40.7 
 2.75 (d, 12.6)  2.78 (d, 12.7)  2.55 (d, 10.0)  
30 3.28 (d, 10.5) 58.5 3.37 (d, 10.5) 59.7 3.27 (d, 10.5) 58.1 
OMe 3.69 (s) 52.2 3.75 (s) 52.5 3.61 (s) 51.8 
OCOMe 2.01 (s) 171.2 2.07 (s) - 2.02 (s) 170.2 
  21.6  -  22.0 
Note: # data reported in the literature. δ in ppm relative to the internal TMS, multiplicities (s, single; d, 
double; t, triplet; m, multiplet; br, broad; and coupling constants (J inHz) are given in brackets. “-“ data are 
absent in the reference. The assignments of H-2, 30 of 14 from the reference were exchanged for 
comparison with a underline marker. a in CDCl3 and trace CD3OD; 
c in DMSO-D6. The proton signals of 
hydroxyls in 14 were also observed as δ 2.86 (d, 9.6, C-3 OH), 2.54 (d, 7.2, C-6 OH). 
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Figure 3-29 ESI-MS (negative ion mode) spectrum of 6 (khayanolide E) 
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Figure 3-30 ESI-MS (positive ion mode) spectrum of 6 (khayanolide E) 
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Figure 3-31 1H NMR spectrum of 6 (khayanolide E) 
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Figure 3-32 13C NMR spectrum of 6 (khayanolide E) 
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Figure 3-33 DEPT135° spectrum of 6 (khayanolide E) 
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Figure 3-34 Crystal structure of 6 (khayanolide E)  
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Table 3-9 Crystal data and structure refinement of 6 
Crystal description Colorless block  
Empirical formula C29H34O11 
Molecular weight 558.56 
Temperature (K) 168 (2) 
Wavelength (Å) 0.71073 
Crystal system, space group Monoclinic, P21 
Unit cell dimensions (Å) a = 12.9096 (18), b = 8.0852 (17),  
c = 14.1008 (19), β = 116.925 (7)º 
Volume (Å3) 1312.3 (5) 
Number of molecules per unit cell, Z 2 
Calculated density (Mg/m3) 1.414  
Absorption coefficient (µ) (mm-1) 0.11 
Diffraction radiation type  Mo Ka 
F(000) 595  
Crystal size 0.53 mm × 0.29 mm × 0.24 mm  
θ range for data collection (°) 3.2 < θ < 25.1 
Limiting indices -15 ≤  h ≤ 15, -9 ≤ k ≤ 9, -16 ≤ l ≤ 15 
Reflections collected / unique 10799 / 4493 [Rint = 0.043]  
Completeness to θ  = 25.05 99.3 %  
Absorption correction REQAB (multi-scan)  
Max. and min. transmission 0.9657 and 0.8673 
Data / restraints / parameters 4493 / 1 / 368 
Goodness-of-fit on F2 1.050 
Final R indices [I > 2 σ (I)] R1 = 0.0391, ωR2 = 0.1009 
R indices (all data) R1 = 0. 0406, ωR2 = 0.1019 
Absolute structure parameter 0.1 (8) 


































































































Figure 3-35 Biogenetic pathways of B,D-seco limonoids 
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3.9 Structure identification of 1-O-deacetylkhayanolide E 7 
Compound 7 is soluble in MeOH but not in CHCl3. Its molecular formula was 
determined to be C27H32O10 (molecular weight 516) based on accurate ESI-MS (positive 
ion model m/z 517.1382 [M+H]+, 539.1089 [M+Na]+, 1033.2683 [2M+H]+, 1055.2358 
[2M+Na]+) (Figure 3-36) and NMR data. 
Its 1D NMR (Figures 3-37 to 3-40) and 2D NMR (Figures 3-41 to 3-43) are similar 
to those of khayanolide E 7 except for the absence of the acetyl group at C-1. The low-
frequency shift of δ 84.0 (C-1) in 7 and δ 90.8 (C-1) in 6 suggests 7 is 1-O-deacetyl 
khayanolide E, a conclusion supported by the 2D NMR experiments. In fact, the NMR 
data of 7 are in good agreement with those reported for 1-O-deacetyl khayanolide E 
isolated from K. grandfolia (Zhang, et al., 2008) and phragmalin derivative 
1α,6,8α,14β,30β-pentahydroxy-3-oxo-[3.3.110,2.11,4]-tricyclomeliac-7-oate 15 (Figure 3-
1), isolated from the stem bark of the same species, K. senegalensis (Olmo et al., 1997). 
Since the only difference between 15 and 14 is a substitute group change at C-1 and 
phragmalin 14 was found to be the same as 6 through X-ray crystallography analysis, it 
was concluded based on spectral correlation that phragmalin 15 is, in fact, 1-O-deacetyl 
khayanolide E 7.  
In addition, the biogenetic pathway indicates the configuration of oxygenated C-6 of 
7 is an S, the same as that of 6. Since different solvents were used in the research for 
these compounds, the NMR data of 7 assigned through 2D NMR experiments are listed 
for comparison in Tables 3-10. It seems there is no significant difference in 13C chemical 
shift value change (< 1 ppm) among those measured in CDCl3, or DMSO-d6, or C5D5N 
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and in the 1H chemical shift value change (< 0.2 ppm) between CDCl3 and DMSO-d6 
while differences are from the 1H NMR data (> 0.5-1 ppm) between CDCl3 and C5D5N. 
The reasons that led the Silvo group (Olmo et al., 1996; Olmo et al., 1997) to 
conclude a phragmalin 15 instead of the khayanolide 7, are perhaps ascribed to the 
following factors similar to those concerning 14 and 6: (1) wrong assignment of the 
observed molecular ion in the EI-MS spectrum reported as EI-MS m/z (rel. int.): 516 [M-
H2O]
+ (73), 378 (100) (Olmo et al., 1997). The 516 ion peak was, in fact, the molecular 
ion peak, just like those EI-MS m/z 516 [M]+ (86), 378 (100) elucidated by the Jianmin 
Yue group (Zhang et al., 2008); (2) they did not consider other possibilities besides 
phragmalin as being compatible with the 2D NMR data; (3) they did not take into account 
the important HMBC correlations between H-30 and C-9, and between H-2 and C-4 
observed in both the experiments reported here and those of the Jieming Yue group 
(Zhang et al., 2008). These correlations proved critical in determining the structural 
similarities and differences between khayanolides and phragmalins. 
Overall, X-ray crystallography results of the structure reported here confirm the 
structure and the stereochemistry 1-O-deacetylkhayanolide B 4 and khayanolide E 6 
reported by the Nakatani group, revealing that the two reported khayanolides 12 and 13 
are, in fact, 1-O-acetylkhayanolide B 4 and khayanolide B 5, respectively, and that the 
two reported phragmalin derivatives 14 and 15 are, in fact, khayanolide E 6 and 1-O-
deacetylkhayanolide E 7, respectively. These incorrect structures 12-15 were cited by 
other research groups in addition to the Nakatani group. (Fall et al., 1999; Mulholland et 
al., 2000; Ferreira et al., 2005; Narender et al., 2007). 
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All the C-6 configurations in these khayanolides were determined to be S, the same 
as that of khayanolide A. In contrast, all the oxygenated C-6 configurations in the 
mexicanolide limonoids from the original mahogany Swietenia genus were reported to be 
R, the same as that of swietenine isolated from Swietenia macrophylla and confirmed to 
have a 6 R configuration through X-ray crystallography (McPhail et al., 1964). Past 
research accepted that methyl 6-hydroxyangolensate is a common precursor (Connolly et 
al., 1964; Taylor, 1984) of further derived C-6 oxygenated limonoids such as 
mexicanolides, phragmalins, and khayanolides. However, the C-6 configuration of the 
methyl 6-hydroxyangolensate was not fully clarified in the past because its 
stereochemistry is unable to be determined through routine spectra. Considering that the 
configuration of oxygenated C-6 does not change during its transformation from methyl 
6-hydroxyangolensate to mexicanolides, phragmalins, and khayanolides, it is reasonable 
to assume the methyl 6-hydroxyangolensate from the K. senegalensis (Adesida et al., 
1967) should have a 6 S configuration while methyl 6-hydroxyangolensate (Saad et al., 
2003) from the Swietenia species should have a 6 R configuration. The methyl 6S-
hydroxyangolensate from K. senegalensis was proposed by Taylor forty years ago, 
though it was not verified at that time (Adesida et al., 1967; Adesogan et al., 1968). The 
results reported here not only confirm the C-6 S configuration assignment of the 
khayanolides but also indirectly support the structure of methyl 6S-hydroxyangolensate 
deduced by the Taylor group. The configuration difference of oxygenated C-6 in B, D-
seco limonoids imply a significant chemotaxonomy between the African mahogany 
Khaya genus and the genuine mahogany Swietenia genus.  
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Table 3-10 NMR data of 7 and those reported in the literature 
Num.  7a 7b, # 15c 
 H C H C H C 
1  84.0  84.8  83.6 
2 4.24 (d, 10.4) 74.8 4.83 (d, 10.4) 75.8 4.37 (d, 10.3)  74.5 
3  206.7  207.3  206.5 
4  49.4  51.8  49.3 
5 3.08 (d, 8.7) 42.2 4.09 (brs) 43.1 3.25 (d, 8.0) 41.9 
6 4.25 (d, 8.7) 70.2 4.90 (brs) 72.7 4.22 (dd,8.0, 5.0) 70.0 
7  174.2  175.9  173.6 
8  87.1  88.5  86.8 
9 2.28 (d, 9.3) 55.3 3.07 (d, 8.7) 56.8 2.28 (brd, 10.0) 54.6 
10  59.5  59.4  59.3 
11 α 2.04 (m) 16.1 2.16 17.1 1.77-1.83 (m) 16.2 
    β 1.81 (m)  1.92  1.90 (m)  
12 α 0.91 (m) 26.4 2.22 26.6 0.85 (brd, 9.0) 26.3 
     β 1.81 (m)  1.08 (brd, 11.2)  1.77-1.83 (m)  
13  37.4  38.4  36.9 
14  83.4  84.3  83.0 
15 α 3.06 (d, 18.8) 33.7 3.83 (d, 18.6) 34.2 3.10 (d, 18.6) 33.1 
    β 2.69 (d, 18.8)  3.36 (d, 18.6)  2.69 (d, 18.6)  
16  172.0  170.4  169.9 
17 5.43 (s) 81.2 5.85 (s) 80.7 5.40 (s) 80.2 
18 1.03 (s) 13.9 1.39 (s) 14.6 1.11 (s) 14.6 
19 1.24 (s) 17.2 1.94 (s) 21.0 1.33 (s) 18.3 
20  120.8  121.9  120.7 
21 7.41 (d, 1.7) 141.2 7.65 (s) 141.7 7.59 (m) 141.5 
22 6.35 (d, 1.7) 110.0 6.55 (brs) 110.9 6.47 (m) 110.4 
23 7.39 (d, 1.7) 142.8 7.64 (s) 143.4 7.56 (m) 143.3 
28 0.91 (s) 14.4 1.72 (s) 16.2 0.99 (s) 15.3 
29 1.72 (d, 12.0) 44.0 2.17 (s) 46.5 1.73 (d, 12.6) 44.3 
 2.03 (d, 12.0)  2.67 (s, 12.2)  2.11 (d, 12.6)  
30 2.73 (d, 10.4) 63.2 3.49 (d, 10.4) 65.1 2.88 (d, 10.3) 62.7 
OMe 3.62 (s) 51.3 3.73 (s) 52.2 3.66 (s) 51.6 
Note: # data reported in the literature. δ in ppm relative to the internal TMS, multiplicities (s, single; d, 
double; t, triplet; m, multiplet; br, broad; and coupling constants (J inHz) are given in brackets. The 
assignments of H-2, 30 of 15 from references were exchanged for comparison with a underline marker. a in 
CDCl3 and trace CD3OD; 
b in C5D5N; 
c in DMSO-D6. 
# reported in the literatures. The proton signals of 
hydroxyls in 15c were also observed at δ 5.44 (d, 5.0), 4.97 (brs), 4.60 (s). The proton signals of hydroxyls 
in 7b,# were at δ 6.99 (brs, C-1 OH), 7.57 (brs, C-6 OH), 7.36 (brs, C-8 OH). 
76 
 
Figure 3-36 Accurate ESI-MS spectrum of 7 (1-O-deacetylkhayanolide E) 
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Figure 3-37 1H NMR spectrum of 7 (1-O-acetylkhayanolide E) 
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Figure 3-38 13C NMR spectrum of 7 (1-O-acetylkhayanolide E) 
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Figure 3-39 DEPT135° spectrum of 7 (1-O-acetylkhayanolide E) 
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Figure 3-40 DEPT90° spectrum of 7 (1-O-acetylkhayanolide E) 
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Figure 3-43 HMBC spectrum of 7 (1-O-deacetylkhayanolide E) 
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3.10 Structure elucidation of 6-dehydroxykhayanolide E 8 
Compound 8 was soluble in CHCl3 but not in MeOH. Its molecular formula was 
determined to be C29H34O10 (molecular weight 542) through LC-ESI-MS (positive ion 
mode Figure 3-45 and negative ion mode Figure 3-46), EI-MS (Figure 3-47), high 
resolution EI-MS (Table 3-12), and NMR data (Table 3-11). As a result, the degree of 
unsaturation is 13. 
The strong IR absorption peaks (3431, 1736, 1703 cm-1) (Figure 3-44) indicate the 
presence of hydroxyl and ester carbonyl groups. The 1H NMR spectrum (Figure 3-48) 
showed the presence of six singlet methyls δ 3.67 (-OMe), 2.02 (-OAc), 1.26, 1.10 and 
0.99. Twenty-nine carbon signals were observed in the 13C NMR spectrum (Figure 3-49). 
Their multiplicities of these carbons determined through DEPT 135° (Figure 3-50) and 
DEPT 90° (Figure 3-51) resulted in 5 CH3, 5 CH2, 8 CH, and 11 C, including one ketone 
carbonyl (δ 204.1), three ester carbonyls (δ 172.5, 170.1, 169.7), a β-substituted furan (δ 
142.8, 141.2, 120.4, 110.1), three oxygenated carbons (δ 90.9, 87.8, 83.5), two 
oxygenated methines (δ 80.1, 74.5), and one oxygenated methyl (δ 52.1). Based on the 
molecular formula and the DEPT spectra, only one hydroxyl group was present in the 
structure. The signals of the β-substituted furan ring in the 1H NMR spectrum occurred at 
δ 7.40 (1H, s, H-23), 7.38 (1H, s, H-21), 6.36 (1H, s, H-22) and the corresponding carbon 
signals at 142.8 (C-23, CH), 141.2 (C-21, CH), 110.2 (C-22, CH), respectively, in the 
HMQC spectrum (Figure 3-52). 
Based on the starting point of the furan ring and the combination of the coupling 
constants in 1H NMR spectrum; chemical shift values in proton and carbon spectra; and 
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the 1H-1H COSY (Figure 3-53), HMBC (Figure 3-54), and NOESY (Figure 3-55) 
correlations, the structure of 8 could be deduced as Figure 3-1, and the connection of 
these structural fragments are shown in Figure 3-56.  
In fact, the NMR data of 8 are similar to those of khayanolide E 6, except for the 
presence of the C-6 methine (1H NMR: 1H, δ 4.32, d, J = 4.8 Hz; 13C NMR: δ 70.7 CH) 
in 6 and the methylene assigned to C-6 (1H NMR 1H, δ 2.46, dd, J = 11.0, 17.0 Hz and 
1H, δ 2.31, dd, J = 4.0, 17.0 Hz; 13C NMR: δ 34.0, CH2) in 8, suggesting 8 was a 6-
dehydroxy derivative of 6. This conclusion was supported through COSY, HMQC, 
HMBC, NOESY experiments and finally confirmed through the single-crystal X-ray 
diffraction (Figure 3-57 and Table 3-13). The full assignments of the NMR data of 6-
dehydroxylkhayanolide E 8 are listed in Table 3-11. 
Similar to those of 1-O-acetylkhayanolide B 4 and khayanolide E 6, the five-
membered-rings A1 (C-1, 29, 4, 5, 10), B1 (C-1, 30, 8, 9 10) and B2 (C-2, 30, 8, 14 and O) 
of compound 8 have half-chair conformations, the furan ring E is planar, and the six-
membered rings C, D exist in a chair conformation. 
For 6-dehydroxykhayanolide E 8, colorless block-shaped crystals were obtained 
from CHCl3 and MeOH solvents, [α]D
20 26 (0.14, CHCl3); IR νmax (KBr) cm-1: 3430 (br), 
2923, 1736 (s), 1703 (s), 1465, 1383, 1242 (s), 1167, 1014, 875; ESI-MS m/z (positive 
ion mode) 543.2 [M+H]+, 1085.5 [2M+H]+, 1107.5 [2M+Na]+; (negative ion mode) 587.4 
[M+HCOOH-H]+, 1083.4 [2M-H]+, EI-MS m/z (rel. int.): 542 [M]+ (65), 446 (48), 404 
(100), 386 (19), 358 (37), 344 (49), 312 (13), 238 (53), 215 (37), 182 (18), 125 (21); 
HREI-MS m/z 542.2151 [M]+ (calcd. for C29H34O10, 542.2152).  
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Table 3-11 NMR data of 8 (δ in ppm) measured in CDCl3 
Num.  H C COSY HMBC (H to C) NOESY 
1  90.9  C    
2 4.42 (d, 10.5) 74.5  CH H-30 C-1, 3, 4 H-15β, 30 
3  204.0 C    
4  51.8  C    
5 3.47 (dd, 11.0, 4.0) 35.3  CH H2-6 C-4, 6, 7, 9,  H-12β, 6 
6 2.46 (dd,11.0, 17.0) 34.0  CH2 H-5, H-6 C-4, 5, 7, 10 H-5, 6, 28 
 2.31 (dd, 4.0, 11.0)   H-5, H-6 C-4, 5, 7, 10 H-6 
7  172.5 C    
8  87.8 C    
9 2.27 (brd, 9.5) 55.8 CH H2-11 C-5, 10, 11, 12, 19 H-6, 11, 19 
10  59.4 C    
11 α 1.98 (m) 16.3 CH2 H-9, 11β, 12 C-12, 13 H-11β,12 
    β 1.52 (m)   H-9, 11 α, 12 C-12, 13 H-11, 12 
12 α 1.04 (m) 25.9 CH2 H-11, 12β C-11 H-11,12β 
     β 1.85 (m)   H-11, 12 α C-11, 13 H-11, 12 
13  37.7 C    
14  83.5 C    
15 α 3.14 (d, 18.5) 32.7 CH2 H-15 α C-8, 16 H-15β, 18 
    β 2.66 (d, 18.5)   H-15β C-8, 13, 16 H-15 
16  169.7 C    
17 5.55 (s) 80.1 CH  C-12, 13, 18, 20, 21, 22 H-12β, 22 
18 1.10 (s) 14.3 CH3  C-12, 13, 14, 18  
19 1.26 (s) 18.5 CH3  C-1, 5, 9, 10  
20  120.5 C    
21 7.39 (s) 141.2 CH  C-20, 22, 23 H-17, 18, 22, 23 
22 6.35 (s) 110.1 CH  C-20, 21, 23 H-17, 18 
23 7.37 (s) 142.8 CH  C-20, 21, 22  H--21, 22 
28 0.99 (s) 15.0 CH3  C-3, 4, 5, 29 H-15β 
29 1.93 (d, 13.5) 40.6 CH2 H-29 C-1, 3, 4, 10  
 3.14 (d, 13.5)   H-29 C-1, 3, 5, 10  
30 3.36 (d, 10.5) 60.0 CH  C-1, 2, 3, 8, 9, 10 H-2, 15β 
OMe 3.67 (s) 52.0 CH3  C-7  
OCOCH3 2.02 (s) 170.1 C    
OCOCH3  21.9 CH3  C-170.1  
 
Note: 1H NMR 500 MHz and 13C 125 MHZ. The important HMBC correlations between 
H-2 and C-4, between H-30 and C-9 are marked in bold. Multiplicities (s, single; d, 





Figure 3-44 IR spectrum of 8 (6-dehydroxylkhayanolide E) 
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Figure 3-45 ESI-MS (positive ion mode) of 8 (6-dehydroxykhayanolide E) 
89 
 
Figure 3-46 ESI-MS (negative ion mode) of 8 (6-dehydroxykhayanolide E) 
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Figure 3-47 EI-MS spectrum of 8 (6-dehydroxykhayanolide E) 
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Table 3-12 HR-EI-MS data of compound 8 (6-dehydroxykhayanolide E) 
Mass Intensity %RA %RIC Delta (mmu) R+D Composition 
71.08617 36755 20.62 0.26 -0.1 0.5 C5 H11 
73.02961 20087 11.27 0.14 -0.7 1.5 C3 H5 O2 
77.03990 12536 7.03 0.09 -0.8 4.5 C6 H5 
79.05588 16098 9.03 0.11 -1.1 3.5 C6 H7 
81.06986 21084 11.83 0.15 0.6 2.5 C6 H9 
83.08552 23506 13.19 0.17 0.6 1.5 C6 H11 
85.10142 30202 16.95 0.21 0.3 0.5 C6 H13 
91.05428 28278 15.87 0.20 0.5 4.5 C7 H7 
93.07042 15599 8.75 0.11 0.0 3.5 C7 H9 
95.04981 18448 10.35 0.13 -0.1 3.5 C6 H7 O 
95.08591 13818 7.75 0.10 0.2 2.5 C7 H11 
97.10145 25500 14.31 0.18 0.3 1.5 C7 H13 
105.0649 27352 15.35 0.19    
111.9883 13676 7.67 0.10    
119.0854 18733 10.51 0.13 0.7 4.5 C9 H11 
121.0653 20657 11.59 0.15 0.0 4.5 C8 H9 O 
123.0804 12607 7.07 0.09 0.5 3.5 C8 H11 O 
125.0602 37752 21.18 0.27 0.0 3.5 C7 H9 O2 
131.0855 16668 9.35 0.12 0.6 5.5 C10 H11 
133.0646 15528 8.71 0.11 0.7 5.5 C9 H9 O 
135.0806 19659 11.03 0.14 0.4 4.5 C9 H11 O 
147.0804 20372 11.43 0.14 0.6 5.5 C10 H11 O 
159.0801 15172 8.51 0.11 0.8 6.5 C11 H11 O 
161.0962 12607 7.07 0.09 0.5 5.5 C11 H13 O 
169.1007 13320 7.47 0.09 1.0 7.5 C13 H13 
177.0916 17024 9.55 0.12 0.0 5.5 C11 H13 O2 
182.0954 32054 17.99 0.23 -1.1 4.0 C10 H14 O3 
188.0843 14246 7.99 0.10 -0.6 7.0 C12 H12 O2 
207.1050 15884 8.91 0.11 -2.9 5.5 C12 H15 O3 
208.1109 31911 17.91 0.22 -1.0 5.0 C12 H16 O3 
214.1006 54492 30.58 0.38 -1.2 8.0 C14 H14 O2 
215.1062 66387 37.25 0.47 1.0 7.5 C14 H15 O2 
216.1134 22366 12.55 0.16 1.6 7.0 C14 H16 O2 
220.1106 17522 9.83 0.12 -0.7 6.0 C13 H16 O3 
237.1163 20585 11.55     
238.1206 94666 53.12 0.67 0.0 5.0 C13 H18 O4 
253.1219 16953 9.51 0.12 0.9 9.5 C17 H17 O2 
271.1330 15599 8.75 0.11 0.4 8.5 C17 H19 O3 
295.1336 12607 7.07 0.09 -0.2 10.5 C19 H19 O3 
312.1364 22580 12.67 0.16 -0.2 10.0 C19 H20 O4 
326.1500 13035 7.31 0.09 1.8 10.0 C20 H22 O4 
327.1584 20016 11.23 0.14 1.2 9.5 C20 H23 O4 
344.1633 86902 48.76 0.61 -0.9 9.0 C20 H24 O5 
345.1591 20799 11.67 0.15    
358.1775 66316 37.21 0.47 0.6 9.0 C21 H26O5 
359.1811 17024 9.55 0.12 -1.1 17.5 C28 H23 
372.1582 23150 12.99 0.16 -0.9 10.0 C21 H24 O6 
386.1724 34689 19.46 0.24 0.5 10.0 C22 H26 O6 
387.1798 25429 14.27 0.18 0.9 9.5 C22 H27 O6 
404.1838 178221 100 1.25 -0.3 9.0 C22 H28 O7 
405.1870 37254 20.90 0.26 -1.5 17.5 C29 H25 O2 
446.1951 85620 48.04 0.60 -1.0 10.0 C24 H30 O8 
447.1989 18448 10.35 0.13    
482.1907 14317 8.03 0.10    
542.2151 115181 64.63 0.81 0.1 13.0 C29 H34 O10 
543.2199 31056 17.43 0.22    
628.9650 13676 7.67 0.10    
 Mode: EI + VE + LMR; R+D: -2.0 > 60.0  
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Figure 3-48 1H NMR spectrum of 8 (6-dehydroxykhayanolide E) 
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Figure 3-49 13C NMR spectrum of 8 (6-dehydroxykhayanolide E) 
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Figure 3-50 DEPT135° spectrum of 8 (6-dehydroxykhayanolide E) 
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Figure 3-51 DEPT90° spectrum of 8 (6-dehydroxykhayanolide E) 
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Figure 3-54 HMBC spectrum of 8 (6-dehydroxylkhayanolide E) 
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Figure 3-56 Structural elucidation of 8 (6-hydroxykhayanolide E)  
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Figure 3-57 Crystal structure of 8 (6-dehydroxykhayanolide E) 
Table 3-13 Crystal data and structure refinement of 8 
Crystal description Colorless block  
Empirical formula C29H34O10 
Molecular weight 542.56 
Temperature (K) 293 (2) 
Wavelength (Å) 0.71073 
Crystal system, space group Monoclinic, P21 
Unit cell dimensions (Å) a = 12.9044 (18), b = 8.0118 (12),  
c = 14.224 (2), β = 116.582 (2)º 
Volume (Å3) 1315.1 (3) 
Number of molecules per unit cell, Z 2 
Calculated density (Mg/m3) 1.370  
Absorption coefficient (µ) (mm-1) 0.10 
Diffraction radiation type  Mo Ka 
F(000) 576  
Crystal size 0.42 mm × 0.36 mm × 0.13 mm  
θ range for data collection (°) 1.6 < θ < 26.0 
Limiting indices -15 ≤  h ≤ 15, -9 ≤ k ≤ 9, -14 ≤ l ≤ 17 
Reflections collected / unique 7213 / 2753 [Rint = 0.082]  
Completeness to θ  = 25.05 99.3 %  
Absorption correction phi and omega scans 
Max. and min. transmission 1.000 and 0.789 
Data / restraints / parameters 2753 / 1 / 359 
Goodness-of-fit on F2 1.078 
Final R indices [I > 2 σ (I)] R1 = 0.0630, ωR2 = 0.1578 
R indices (all data) R1 = 0. 0706, ωR2 = 0.1617 
Largest diff. peak and hole (e Å-3) 0.25 and -0.26 
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3.11 Structure identification of compounds 9-11 
The molecular formula of 9 was determined to be C22H28O8 through accurate ESI-
MS (Figure 3-58) and NMR spectra (Figures 3-59 to 3-65). Its structure was identified 
as (-)-lyoniresinol because the NMR data were in good agreement with those previously 
reported (Dada et al., 1989; Hanawa et al., 1997). 
The molecular formula of 10 was determined to be C27H36O12 through accurate ESI-
MS (Figure 3-66) and NMR data. Its structure was characterized as (-) lyoniresin-9-yl-β-
D-xylopyranoside because the NMR data were consistent with those previously reported 
in the literature (Miyamura et al., 1983; Smite et al., 1995). Furthermore, the downfield 
shift of C-9 from δ 63.9 in 9 to δ 70.9 in 10, the large coupling constant of H-1′′ (δ 4.20, 
1H, d, J = 7.5 Hz), and the HMBC correlations of H-9 with C-1′′ and H-1′′ with C-9 
indicated a β-xylose attachment at the C-9 position.  
The molecular formula of 11 was determined to be C28H38O13 through accurate ESI-
MS (Figure 3-67) and NMR data. Its structure was shown to be (-) lyoniresin-4'-yl-β-D-
glucopyranoside because these data were in good accord with those previously reported 
(Buske et al., 2001). The large coupling constant of the anomeric proton (δ 4.87, 1H, d, J 
= 8.0 Hz, H-1′′), the HMBC correlation between H-1′′ and C-4′ (δ 138.3), and the 
downfield shift values of C-3′ from δ 148.4 in 9 to δ 152.9 in 11 and C-5′ from δ 147.4 in 
9 to δ 152.3 in 11 confirmed a β-glucose attachment at the C-9 position. All the 1H and 
13NMR data of 9-11 were unambiguously assigned on the basis of the DEPT (90 and 135), 
1H-1H COSY, HMQC and HMBC experiments.  
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This isolation of these three compounds is the first report of these lignans in Africa 
mahogany Khaya species. 
(-) lyoniresinol (9): C22H28O8, molecular weight 420, colorless needles from CHCl3 
and MeOH solvents, 1H NMR (500 MHz, in CD3OD) δ 6.39 (2H, s, H-2 and H-6), 4.33 
(1H, d, J = 6.0 Hz, H-7), 1.98 (1H, m, H-8), 3.45 (2H, m, H2-9), 3.75 (6H, s, H3-3-OMe 
and H3-5-OMe), 6.62 (1H, s, H-2′), 2.73 (1H, dd, J = 15.0, 5.0, H-7′a), 2.60 (1H, dd, J = 
15.0, 11.0, H-7′b); 1.62 (1H, m, H-8′), 3.62 (1H, dd, J = 11.0, 5.0, H-9′a), 3.51 (1H, dd, J 
= 11.0, 6.5, H-9′b), 3.40 (3H, s, H3-3′-OMe), 3.88 (3H, s, H3-5′-OMe); 13C NMR (125 
MHz, in CD3OD) δ 139.0 (s, C-1), 106.6 (d, C-2), 148.5 (s, C-3), 134.2 (s, C-4), 148.5 (s, 
C-5), 106.6 (s, C-6), 42.0 (d, C-7), 48.7 (d, C-8), 63.9 (t, C-9), 56.5 (q, 3, 5 OMe), 129.9 
(s, C-1′), 107.5 (d, C-2′), 148.4 (s, C-3′), 138.6 (s, C-4′), 147.4 (s, C-5′), 126.0 (s, C-6′), 
33.3 (t, C-7′), 40.6 (d, C-8′), 66.5 (t, C-9′), 59.8 (q, 3′-OMe), 56.3 (q, 5′-OMe); accurate 
ESI-MS (positive ion mode): m/z [M+Na]+ 443.1450, [2M+Na]+ 863.3193.  
lyoniresin-9-yl-β-D-xylopyranoside (10): C27H36O12, molecular weight 552, 
amorphous, 1H NMR (300 MHz, in CD3OD) δ 6.40 (2H, s, H-2 and H-6), 4.30 (1H, d, J 
= 6.0 Hz, H-7), 1.99 (1H, m, H-8), 3.52 (1H, m, H-9a), 3.92 (1H, m, H-9b), 3.74 (6H, s, 
H3-3-OMe and H3-5-OMe), 6.60 (1H, s, H-2′), 2.71 (1H, dd, J = 15.0, 5.0, H-7′a), 2.62 
(1H, dd, J = 15.0, 11.2, H-7′b); 1.69 (1H, m, H-8′), 3.63 (1H, dd, J = 11.0, 4.6, H-9′a), 
3.51 (1H, dd, J = 11.0, 6.5, H-9′b), 3.37 (3H, s, H3-3′-OMe), 3.86 (3H, s, H3-5′-OMe), 
4.20 (1H, d, J = 7.5 Hz, H-1′′), 3.20 (1H, m, H-2′′), 3.30 (1H, m, H-3′′), 3.48 (1H, m, H-
4′′), 3.16 (1H, dd, J = 11.5, 10.2 Hz, H-6′′a), 3.82 (1H, dd, J = 11.5, 5.5 Hz, H-6′′b);13C 
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NMR (75 MHz, in CD3OD) δ 139.0 (s, C-1), 106.5 (d, C-2), 148.6 (s, C-3), 134.1 (s, C-4), 
148.6 (s, C-5), 106.5 (s, C-6), 42.6 (d, C-7), 46.1 (d, C-8), 70.9 (C-9), 56.8 (q, 3,5-OMe), 
129.9 (s, C-1′), 107.7 (d, C-2′), 148.3 (s, C-3′), 138.5 (s, C-4′), 147.3 (s, C-5′), 126.1 (s, 
C-6′), 33.7 (t, C-7′), 40.7 (d, C-8′), 65.7 (t, C-9′), 60.1 (q, 3′-OMe), 56.5 (q, 5′-OMe), 
103.8 (d, C-1′′), 74.7 (d, C-2′′), 77.5 (d, C-3′′), 71.2 (d, C-4′′), 66.7 (t, C-5′′). Accurate 
ESI-MS (positive ion mode) m/z  575.2018 [M+Na]+ . 
lyoniresin-4'-yl-β-D-glucopyranoside (3): C28H38O13, molecular weight 582, 
amorphous, 1H NMR (300 MHz, in CD3OD) δ 6.38 (2H, s, H-2 and H-6), 4.27 (1H, d, J 
= 5.7 Hz, H-7), 1.96 (1H, m, H-8), 3.45 (2H, m, H2-9), 3.78 (6H, s, H3-3-OMe and H3-5-
OMe), 6.69 (1H, s, H-2′), 2.74 (1H, dd, J = 15.0, 5.0, H-7′a), 2.60 (1H, dd, J = 15.0, 11.0, 
H-7′b); 1.67 (1H, m, H-8′), 3.60 (1H, dd, J = 11.0, 5.0, H-9′a), 3.50 (1H, dd, J = 11.0, 6.5, 
H-9′b), 3.40 (3H, s, H3-3′-OMe), 3.88 (3H, s, H3-5′-OMe), 4.87 (1H, d, J = 8.0 Hz, H-1′′), 
3.42 (1H, m, H-2′′), 3.37 (1H, m, H-3′′), 3.39 (1H, m, H-4′′), 3.15 (1H, m, H-5′′), 3.63 
(1H, dd, J = 11.0, 6.0 Hz, H-6′′a), 3.72 (1H, dd, J = 11.0, 2.2 Hz, H-6′′b); 13C NMR (75 
MHz, in CD3OD) δ 139.1 (s, C-1), 106.5 (d, C-2), 148.8 (s, C-3), 134.3 (s, C-4), 148.8 (s, 
C-5), 106.5 (s, C-6), 42.5 (d, C-7), 48.5 (d, C-8), 62.8 (t, C-9), 56.5 (q, 3, 5 OMe), 134.8 
(s, C-1′), 108.7 (d, C-2′), 152.9 (s, C-3′), 138.3 (s, C-4′), 152.3 (s, C-5′), 126.7 (s, C-6′), 
33.7 (t, C-7′), 39.9 (d, C-8′), 65.9 (t, C-9′), 56.5 (q, 3′-OMe), 61.0 (q, 5′-OMe); 103.7 (d, 
C-1′′), 75.6 (d, C-2′′), 77.5 (d, C-3′′), 71.0 (d, C-4′′), 78.0 (d, C-5′′), 62.1 (d, C-6′′). 
Accurate ESI-MS (positive ion mode): m/z [M+Na]+ 605.2111. 
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Figure 3-58 Accurate ESI-MS spectrum of 9 (lyoniresinol) 
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Figure 3-59 1H NMR spectrum of 9 (lyoniresinol) 
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Figure 3-60 13C NMR spectrum of 9 (lyoniresinol) 
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Figure 3-61 DEPT135° spectrum of 9 (lyoniresinol) 
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Figure 3-62 DEPT90° spectrum of 9 (lyoniresinol) 
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Figure 3-63 HMQC spectrum of 9 (lyoniresinol) 
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Figure 3-64 1H-1H COSY spectrum of 9 (lyoniresinol) 
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Figure 3-65 HMBC spectrum of 9 (lyoniresinol) 
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Figure 3-66 Accurate ESI-MS spectrum of 10 
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Figure 3-67 Accurate ESI-MS spectrum of 11 
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Chapter 4 BIOASSAY OF THE ISOLATES 
4.1 Introduction 
All 11 isolates were tested in vitro for their anti-oxidant activities using a DPPH 
bioassay and anti-tumor activities (Figure 4-1) against different tumor cells. (-)-
lyoniresinol 9, (-) lyoniresin-9-yl-β-D-xylopyranoside 10, and (-)-lyoniresin-4'-yl-β-D-
glucopyranoside 11 (Figure 3-1) exhibited potent antioxidant activity comparable to the 
standard BHT of the DPPH radical scavenging test (Figure 4-2) while others did not. It 
appears the glucose moiety attached to the aromatic ring phenol hydroxyl group enhanced 
the anti-oxidant ability. 
Among the 11 isolates, two D-seco limonoids, 3α, 7α-dideacetylkhivorin 1 and 1α, 
3α, 7α-trideacetylkhivorin 2 (Figure 3-1), showed significant growth inhibitory activities 
against MCF-7, Caco-2 and SiHa cancer cell lines with IC50 values in the range of 35-69 
µg/ml (Figure 4-1), while other compounds showed no activity even at the high 
concentration of 200 µg/ml. 
These findings are the first report of the anti-tumor and anti-oxidant activities of 
these natural chemicals. The research results obtained here provide solid scientific 







4.2 Experiments and methods 
Anti-proliferative activities of isolates against different cancer cells 
Sodium pyruvate, sterile cell culture penicillin, streptomycin, Rosewell Park 
Memorial Institute 1640 (RPMI 1640), medium sodium bicarbonate, and trypsin EDTA 
solution were purchased from Sigma Chemical Co. (St. Louis, MO). Tissue culture plates 
were purchased from Costar (Cambridge, MA). Cosmic calf serum and fetal bovine 
serum were purchased from Hyclone (Logan, Utah). 
Three cancer cell lines, MCF-7 (human breast cancer), Caco-2 (human colon 
cancer), and SiHa (cervical cancer) were purchased from American Type Culture 
Collection (ATCC) (Rockville, MD). MCF-7 and SiHa were cultured in RPMI-1640 with 
L-glutamine (2 mM), sodium pyruvate (1 mM), penicillin (100 unit/mL), streptomycin 
(0.1 mg/mL), 0.1 mM non-essential amino acids, 1.5 g/L sodium bicarbonate and 10% 
cosmic calf serum. Caco-2 cells were grown in RPMI medium with 20% fetal bovine 
serum instead of 10% cosmic calf serum. All cells were incubated at 37 oC with 5% CO2 
at 90-100% relative humidity. Medium renewal was conducted 2-3 times per week, and 
cells were sub-cultured when they reached approximately 80-90% confluence.  
Prior to chemical treatment, 104 cells/well (100 µL) were seeded into a 96-well 
tissue culture plate and allowed to attach for 24 hours, then treated with defined 
concentrations of the tested chemicals in DMSO to obtain final concentrations of 200, 
100, 50, 20 and 2 ppm. The DMSO concentration was kept at 2% per well. The negative 
control was the cells treated with DMSO only. Gossypol, an NIH-patented therapeutic 
agent for human cancer patients (Flack et al., 2000), was used as a positive control. After 
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an incubated period of 24 hours, cell proliferation was determined using the CellTiter 96® 
aqueous nonradioactivity cell proliferation assay according to the manufacturer’s 
recommendations (Promega, Madison, WI) and recorded on a Bio-Tek microplate reader 
at 490 nm. The 50% inhibition concentration (IC50) was specified as the chemical 
concentration causing 50% inhibition of cell growth. Triplicates were conducted for each 
concentration of the tested chemicals. All the experiments were done at least three times 
on different days. 
DPPH free radical-scavenging activity of the isolates 
The antioxidant potency of the isolates were measured using the 2, 2-diphenyl-1-
picrylhydrazyl radical (DPPH) free radical scavenging activity method of Chung et al. 
(Chung, et al. 2002) with minor modifications.  
A 400 µL MeOH solution of the candidate samples was added to 400 µL of a 250 
µM DPPH solution dissolved in methanol, to reach a final concentration of 125 µM 
DPPH. The mixture was shaken vigorously and incubated at room temperature in the 
darkness for 30 min. Absorbance of the resulting solutions was measured at 517 nm using 
the Spectronic@ 20 GENESYS TM spectrometer (Fisher Scientific Co. Fairlawn, NJ, USA) 
and using a 400 µL DPPH˙ solution plus a 400 µL methanol as the blank control and 
BHT (butylated hrdroxytoluene) as the antioxidant standard. The discoloration of the 
DPPH˙ solution indicated the presence of antioxidant chemicals, and lower absorbance of 
the reaction mixture indicated higher free radical scavenging activity.  
The scavenging activity of free radical was determined using the equation following: 
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absorbance  of  sample at  517 nm
Scavenging Effect (%) (1 )  100               
absorbance  of  control at  517 nm
= − ×
 
Statistical analysis  
Data were reported as the mean ± standard deviation. All statistical analysis was 
conducted using the SAS V9.1 software for Windows (SAS Institute Inc., Cary, NC, 
USA). Differences among all sample means were determined by analysis of variance 
(one–way analysis of variance, ANOVA), p < 0.05. 
4.3 Anti-tumor assay results 
Compounds 1 and 2 with the positive control gossypol were tested in vitro for 
their antiproliferative activites against the three cancer cell lines MCF-7, Caco-2 and 
SiHa. The results indicated that the growth of MCF-7, Caco-2 and SiHa cells was 
significantly inhibited by various concentrations of 1 and 2 in a dose-dependent manner 
(Figure 4-1). The highest tested concentration of 200 µg/ml inhibited cell growth 
approximately 66% for MCF-7, 70% for Caco-2 and 61% for SiHa. The IC50 values of 1 
were 69, 35, and 54 µg/ml for MCF-7, Caco-2 and SiHa, respectively. The positive 
control gossypol resulted in IC50 values of 24, 17, and 14 µg/ml, for the corresponding 
cell lines of MCF-7, Caco-2 and SiHa, respectively. In contrast, compounds 3-11 were 
weaker inhibitors of cell growth than 1, 2, and gossypol, showing less than 10% 
inhibition of cell growth for MCF-7 and SiHa, and less than 18% inhibition for Caco-2, 
even at a concentration of 200 µg/ml. The antiproliferative bioactivity of the compounds 
1 and 2 may be due to their 14,15β–epoxide moiety. Limonoids including such a 
functional group (for example, gedunin inhibited the growth of Caco-2 with an IC50 value 
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of 8 µg/ml; see Uddin et al., 2007) were reported having a wide range of anti-feedant, 
anti-fungal, and anti-bacterial activities (Balunasa et al., 2006; Champagne et al., 1992; 
Roy et al., 2006). These results appear to be the first report of anti-tumor activity of 
limonoids isolated from K. senegalensis although the molecular mechanism for how 1, 2 
or the reported gedunin (Uddin et al., 2007) inhibit cancer cell growth is not known. 
These results indicate that the anticancer agents 1 and 2 merit further investigation. 
4.4 Anti-oxidant assay results 
Figure 4-2 and Table 4-1 represent the DPPH free radical scavenging activity of 
the isolates 9-11 and BHT at different concentrations (µg/ml). The results reported here 
are the first description of the anti-oxidant capacity of these lignans, although they were 
previously isolated from difference natural sources before (see Chapter 3). The lignans 9-
11 exhibited strong antioxidant activities at the concentration of 100 µg/ml. Among those 
isolates, the strongest antioxidant is compound 11, which exhibited 88% DPPH free 
radical scavenging activities, comparable to those of BHT; In addition, compound 11 
exhibited significantly higher antioxidant activity than 9 and 10, which showed 
approximately 80%. Since both 10 and 11 have the same aglycone 9, it was concluded 
that the glucose moiety attached to C-4′ in the aromatic ring in 11 enhanced the 
antioxidant capacity, while the xylose moiety attached to C-9 in the side chain of 10 did 
not significantly affect the anti-oxidant ability. Although antioxidant activities of lignans 
are regarded into be correlated to anti-cancer activities (Saleem et al., 2005), the bioassay 
results of compounds 1-2 and 9-11 reported here didn’t support there is a direct 
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Conc.(µg/ml) 100 10 1 
9 80.37±0.64c 24.09±0.36c 3.56±0.73c 
10 79.89±0.48c 21.44±0.66b 3.56±0.55c 
11 88.04±0.65b 42.99±1.00a 9.35±0.46b 
BHT 92.28±0.398a 42.26±1.25a 11.71±0.43a 
 
Note: Each value (DPPH free radical scavenging activity) is expressed as mean ± SD (n = 3). Values 
within a column followed by a different letter represent a significant difference at p < 0.05. 
 
Figure 4-2 Dose-response curves of antiradical capacity of 9-11 and BHT 
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CHAPTER 5 SUMMARY 
Guided by the anti-tumor and anti-oxidant bioassays, 11 compounds were isolated 
and screened from the stem bark of medicinal plant African mahogany Khaya 
senegalensis (Meliaceae) by modern column chromatography and crystallization. Their 
structures (Figure 3-1) were identified and elucidated as 8 limonoids:  3α, 7α-
dideacetylkhivorin 1, 1α, 3α, 7α-trideacetylkhivorin 2, khayanone 3, 1-O-
acetylkhayanolide B 4, khayanolide B 5, khayanolide E 6, 1-O-deacetylkhayanolide E 7, 
6-dehydroxylkhayanolide E 8, and 3 lignans: (-)-lyoniresinol 9, (-) lyoniresin-9-yl-β-D-
xylopyranoside 10, (-)-lyoniresin-4'-yl-β-D-glucopyranoside 11 based on the 
spectroscopic determination through IR, MS (EI-MS, HR-EI-MS, LC-ESI-MS, accurate 
ESI-MS), 1D and 2D NMR (1H, 13C, DEPT 90° and 135°, 1H-1H COSY, HMQC or 
HSQC, HMBC, and NOESY), and single crystal X-ray diffraction analysis. 
The structures and the stereochemistry of 1, 2, 3, 4, 6, and the new compound 8 
were confirmed by the single crystal X-ray diffraction experiments. Four reported 
limonoids 12-15 (Figure 3-1) in the literatures were revised to be 4, 5, 6, and 7, 
respectively, based on our obtained data. The main reasons led to the incorrect deduction 
in the literatures were discussed. 
Ring D-seco limonoids 1 and 2 showed significant growth inhibitory activities 
against MCF-7, Caco-2 and SiHa cell lines with IC50 values in the range of 35-69 µg/ml. 
The DPPH assay demonstrated lignans 9, 10, and 11 were strong anti-oxidants 
comparable to BHT. The relationship between structure and activity were discussed. 
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Our research work has provided scientific proof of the traditional medicinal use of 
the stem bark of K. senegalensis, which can be a new candidate for screening novel 
anticancer agents. In addition, we appreciate financial support from South Carolina 
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